<SEC-DOCUMENT>0001104659-25-017490.txt : 20250226
<SEC-HEADER>0001104659-25-017490.hdr.sgml : 20250226
<ACCEPTANCE-DATETIME>20250226170439
ACCESSION NUMBER:		0001104659-25-017490
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20250226
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250226
DATE AS OF CHANGE:		20250226

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AbbVie Inc.
		CENTRAL INDEX KEY:			0001551152
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				320375147
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35565
		FILM NUMBER:		25671203

	BUSINESS ADDRESS:	
		STREET 1:		1 NORTH WAUKEGAN ROAD
		CITY:			NORTH CHICAGO
		STATE:			IL
		ZIP:			60064
		BUSINESS PHONE:		(847) 932-7900

	MAIL ADDRESS:	
		STREET 1:		1 NORTH WAUKEGAN ROAD
		CITY:			NORTH CHICAGO
		STATE:			IL
		ZIP:			60064
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm255723d7_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:abbv="http://abbvie.com/20250226">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_abbv_abbvie.com_20250226 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20250226_20250226 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0001551152 -->
<!-- Field: Set; Name: xdx; ID: xdx_072_SO_T%2D%2D\DeptFiles%2DiXBRL 8%2DK Covers Templates\+++%2DROOT%2DElement%2D+++\DocumentInformationLineItems.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Arial, Helvetica, Sans-Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000004" name="dei:EntityCentralIndexKey">0001551152</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2025-02-262025-02-26_exch_XCHI_us-gaap_CommonStockMember" id="xdx2ixbrl0046" name="dei:Security12bTitle">Common Stock, $0.01 Par Value</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2025-02-262025-02-26_exch_XCHI_us-gaap_CommonStockMember" id="xdx2ixbrl0047" name="dei:TradingSymbol">ABBV</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="abbv-20250226.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-02-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-26</xbrli:startDate>
        <xbrli:endDate>2025-02-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-262025-02-26_us-gaap_CommonStockMember_exch_XNYS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-26</xbrli:startDate>
        <xbrli:endDate>2025-02-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-262025-02-26_exch_XCHI_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XCHI</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-26</xbrli:startDate>
        <xbrli:endDate>2025-02-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-262025-02-26_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes0.750Percentdue2027Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-26</xbrli:startDate>
        <xbrli:endDate>2025-02-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-262025-02-26_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes2.125Percentdue2028Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-26</xbrli:startDate>
        <xbrli:endDate>2025-02-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-262025-02-26_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes2.625Percentdue2028Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-26</xbrli:startDate>
        <xbrli:endDate>2025-02-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-262025-02-26_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes2.125Percentdue2029Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-26</xbrli:startDate>
        <xbrli:endDate>2025-02-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-262025-02-26_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes1.250Percentdue2031Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-26</xbrli:startDate>
        <xbrli:endDate>2025-02-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<p style="margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><p style="margin: 0pt 0">&#160;</p>

<p style="font: bold 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">UNITED
STATES</span></p>

<p style="font: bold 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">SECURITIES
AND EXCHANGE COMMISSION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Washington,
D.C. 20549</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM <span id="xdx_906_edei--DocumentType_c20250226__20250226_z6oEaxELsAa8"><ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000010" name="dei:DocumentType">8-K</ix:nonNumeric></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT
REPORT</span></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 13  OR 15(d) of the</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
Exchange Act of 1934</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event
reported):</b> <b><span id="xdx_904_edei--DocumentPeriodEndDate_c20250226__20250226_zUDTwR06AFFe"><ix:nonNumeric contextRef="AsOf2025-02-26" format="ixt:datemonthdayyearen" id="Fact000011" name="dei:DocumentPeriodEndDate">February 26, 2025</ix:nonNumeric>
</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 20pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_904_edei--EntityRegistrantName_c20250226__20250226_z9Nr8xbeANwe" style="font-size: 18pt"><ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000012" name="dei:EntityRegistrantName">ABBVIE
INC.</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified in its charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="width: 32%; font-weight: bold; text-align: center"><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20250226__20250226_zrhiDCCAMVol"><ix:nonNumeric contextRef="AsOf2025-02-26" format="ixt-sec:stateprovnameen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></td>
    <td style="width: 2%; font-weight: bold; text-align: center">&#160;</td>
    <td style="width: 32%; font-weight: bold; text-align: center"><span id="xdx_90A_edei--EntityFileNumber_c20250226__20250226_zjwfRGqRy0of"><ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000014" name="dei:EntityFileNumber">001-35565</ix:nonNumeric></span></td>
    <td style="width: 2%; font-weight: bold; text-align: center">&#160;</td>
    <td style="width: 32%; font-weight: bold; text-align: center"><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20250226__20250226_zwim8Rx7MK2h"><ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000015" name="dei:EntityTaxIdentificationNumber">32-0375147</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><b>(State of Incorporation)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>(Commission <br/>
File Number)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>(IRS Employer<br/> Identification Number)</b></td></tr>
</table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 1pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90A_edei--EntityAddressAddressLine1_c20250226__20250226_zazHNXustSNe"><ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000016" name="dei:EntityAddressAddressLine1">1
North Waukegan Road</ix:nonNumeric></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90D_edei--EntityAddressCityOrTown_c20250226__20250226_zFsIg97mstNi"><ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000017" name="dei:EntityAddressCityOrTown">North
Chicago</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressStateOrProvince_c20250226__20250226_zmkgZuUJWkY9"><ix:nonNumeric contextRef="AsOf2025-02-26" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Illinois</ix:nonNumeric></span> <span id="xdx_902_edei--EntityAddressPostalZipCode_c20250226__20250226_zJ6t325HfOaa"><ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000019" name="dei:EntityAddressPostalZipCode">60064-6400</ix:nonNumeric></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>(Address
of principal executive offices, including zip code)&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(<span id="xdx_907_edei--CityAreaCode_c20250226__20250226_zb6Lxw7FxoTi"><ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000020" name="dei:CityAreaCode">847</ix:nonNumeric></span></b><b>)
<span id="xdx_905_edei--LocalPhoneNumber_c20250226__20250226_zBIo7Jtqspjh"><ix:nonNumeric contextRef="AsOf2025-02-26" id="Fact000021" name="dei:LocalPhoneNumber">932-7900</ix:nonNumeric></span></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(<b>Registrant&#8217;s telephone
number, including area code</b>)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: left">Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="padding-bottom: 1pt; width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_90E_edei--WrittenCommunications_c20250226__20250226_zPoPBmM9dA2i"><ix:nonNumeric contextRef="AsOf2025-02-26" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1pt; text-align: justify">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr>

<tr style="vertical-align: top">
    <td style="padding-bottom: 1pt; width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_901_edei--SolicitingMaterial_c20250226__20250226_zuM4KlnGpuh1"><ix:nonNumeric contextRef="AsOf2025-02-26" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1pt; text-align: justify">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>

<tr style="vertical-align: top">
    <td style="padding-bottom: 1pt; width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_908_edei--PreCommencementTenderOffer_c20250226__20250226_zjP9shASnKxh"><ix:nonNumeric contextRef="AsOf2025-02-26" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1pt; text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>

<tr style="vertical-align: top">
    <td style="padding-bottom: 1pt; width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_90F_edei--PreCommencementIssuerTenderOffer_c20250226__20250226_zqqrpP1OKI24"><ix:nonNumeric contextRef="AsOf2025-02-26" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1pt; text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: left">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left">Emerging growth company <span style="font-family: Wingdings"><span id="xdx_903_edei--EntityEmergingGrowthCompany_c20250226__20250226_zgA0TeuouM5f"><ix:nonNumeric contextRef="AsOf2025-02-26" format="ixt:booleanfalse" id="Fact000026" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: left">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
registered pursuant to Section 12(b) of the Act:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 32%; font-weight: bold; text-align: center; padding-left: 5.4pt; vertical-align: bottom"><span style="font-size: 9pt">Title
    of each class</span></td>
    <td style="width: 2%; font-weight: bold; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 32%; font-weight: bold; text-align: center; padding-left: 5.4pt; vertical-align: bottom"><span style="font-size: 9pt">Trading
    Symbol(s)</span></td>
    <td style="width: 2%; font-weight: bold; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 32%; font-weight: bold; text-align: center"><span style="font-size: 9pt">Name
    of each exchange on which registered</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center; padding-left: 5.4pt"><span id="xdx_902_edei--Security12bTitle_c20250226__20250226__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__dei--EntityListingsExchangeAxis__exch--XNYS_znTsK18aC6ta" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-262025-02-26_us-gaap_CommonStockMember_exch_XNYS" id="Fact000027" name="dei:Security12bTitle">Common
    Stock, $0.01 Par Value</ix:nonNumeric></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_903_edei--TradingSymbol_c20250226__20250226__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__dei--EntityListingsExchangeAxis__exch--XNYS_z5JkjmukoU9c" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-262025-02-26_us-gaap_CommonStockMember_exch_XNYS" id="Fact000028" name="dei:TradingSymbol">ABBV</ix:nonNumeric></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_900_edei--SecurityExchangeName_c20250226__20250226__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__dei--EntityListingsExchangeAxis__exch--XNYS_zXb2k5wOHgxd" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-262025-02-26_us-gaap_CommonStockMember_exch_XNYS" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">New
    York Stock Exchange</ix:nonNumeric></span> <span style="font-size: 9pt"><br/><span id="xdx_900_edei--SecurityExchangeName_c20250226__20250226__dei--EntityListingsExchangeAxis__exch--XCHI__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zERMm9VEMOyk"><ix:nonNumeric contextRef="From2025-02-262025-02-26_exch_XCHI_us-gaap_CommonStockMember" format="ixt-sec:exchnameen" id="Fact000030" name="dei:SecurityExchangeName">Chicago
    Stock Exchange</ix:nonNumeric></span></span></td></tr>

<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_905_edei--Security12bTitle_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes0.750Percentdue2027Member__dei--EntityListingsExchangeAxis__exch--XNYS_zeQ5PNKQGpPj" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS" id="Fact000031" name="dei:Security12bTitle">0.750%
    Senior Notes due 2027</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_906_edei--TradingSymbol_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes0.750Percentdue2027Member__dei--EntityListingsExchangeAxis__exch--XNYS_zzoDeNtvVsEh" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS" id="Fact000032" name="dei:TradingSymbol">ABBV27</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_903_edei--SecurityExchangeName_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes0.750Percentdue2027Member__dei--EntityListingsExchangeAxis__exch--XNYS_zyFXkJJj0zV9" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS" format="ixt-sec:exchnameen" id="Fact000033" name="dei:SecurityExchangeName">New
    York Stock Exchange</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_edei--Security12bTitle_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.125Percentdue2028Member__dei--EntityListingsExchangeAxis__exch--XNYS_zpkssIVFtete" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS" id="Fact000034" name="dei:Security12bTitle">2.125%
    Senior Notes Due 2028</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_90A_edei--TradingSymbol_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.125Percentdue2028Member__dei--EntityListingsExchangeAxis__exch--XNYS_zdSyXXb1bKoj" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS" id="Fact000035" name="dei:TradingSymbol">ABBV28</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_908_edei--SecurityExchangeName_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.125Percentdue2028Member__dei--EntityListingsExchangeAxis__exch--XNYS_zrkLsA7cc5i8" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS" format="ixt-sec:exchnameen" id="Fact000036" name="dei:SecurityExchangeName">New
    York Stock Exchange</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_903_edei--Security12bTitle_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.625Percentdue2028Member__dei--EntityListingsExchangeAxis__exch--XNYS_zFOjRtEbPtN8" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS" id="Fact000037" name="dei:Security12bTitle">2.625%
    Senior Notes Due 2028</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_909_edei--TradingSymbol_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.625Percentdue2028Member__dei--EntityListingsExchangeAxis__exch--XNYS_zgET2b1r1Enb" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS" id="Fact000038" name="dei:TradingSymbol">ABBV28B</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_90F_edei--SecurityExchangeName_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.625Percentdue2028Member__dei--EntityListingsExchangeAxis__exch--XNYS_zf0hULVCo367" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS" format="ixt-sec:exchnameen" id="Fact000039" name="dei:SecurityExchangeName">New
    York Stock Exchange</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_904_edei--Security12bTitle_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.125Percentdue2029Member__dei--EntityListingsExchangeAxis__exch--XNYS_zXv5U3MGo5lf" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS" id="Fact000040" name="dei:Security12bTitle">2.125%
    Senior Notes due 2029</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_909_edei--TradingSymbol_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.125Percentdue2029Member__dei--EntityListingsExchangeAxis__exch--XNYS_z6cB302Y6E7l" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS" id="Fact000041" name="dei:TradingSymbol">ABBV29</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_902_edei--SecurityExchangeName_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.125Percentdue2029Member__dei--EntityListingsExchangeAxis__exch--XNYS_zOyq6Qj9Pynb" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS" format="ixt-sec:exchnameen" id="Fact000042" name="dei:SecurityExchangeName">New
    York Stock Exchange</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_909_edei--Security12bTitle_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes1.250Percentdue2031Member__dei--EntityListingsExchangeAxis__exch--XNYS_zyHFLNqSdNz8" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS" id="Fact000043" name="dei:Security12bTitle">1.250%
    Senior Notes due 2031</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_903_edei--TradingSymbol_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes1.250Percentdue2031Member__dei--EntityListingsExchangeAxis__exch--XNYS_z1moEufQSukj" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS" id="Fact000044" name="dei:TradingSymbol">ABBV31</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_90A_edei--SecurityExchangeName_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes1.250Percentdue2031Member__dei--EntityListingsExchangeAxis__exch--XNYS_zjs8oYn4E8Fb" style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-02-262025-02-26_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS" format="ixt-sec:exchnameen" id="Fact000045" name="dei:SecurityExchangeName">New
    York Stock Exchange</ix:nonNumeric></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_edei--Security12bTitle_dxL_c20250226__20250226__dei--EntityListingsExchangeAxis__exch--XCHI__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zQsQePMjN0t9" style="display: none; visibility: hidden"><span style="-sec-ix-hidden: xdx2ixbrl0046">Common Stock, $0.01 Par Value</span></span></span></td>
<td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_edei--TradingSymbol_dxL_c20250226__20250226__dei--EntityListingsExchangeAxis__exch--XCHI__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zPCAm1ki5L5i" style="display: none; visibility: hidden"><span style="-sec-ix-hidden: xdx2ixbrl0047">ABBV</span></span></span></td>
</tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in; text-align: left"><b>Item 8.01.</b></td><td style="text-align: justify"><b>Other Events.</b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On February&#160;26, 2025, AbbVie Inc. (&#8220;<span style="text-decoration: underline">AbbVie</span>&#8221;)
completed its previously announced underwritten public offering (the &#8220;<span style="text-decoration: underline">Notes Offering</span>&#8221;) of $1,250,000,000 billion in
aggregate principal amount of its 4.650% senior notes due 2028 (the &#8220;<span style="text-decoration: underline">2028 Notes</span>&#8221;), $1,000,000,000 in aggregate principal
amount of its 4.875% senior notes due 2030 (the &#8220;<span style="text-decoration: underline">2030 Notes</span>&#8221;), $1,000,000,000 in aggregate principal amount of its
5.200% senior notes due 2035 (the &#8220;<span style="text-decoration: underline">2035 Notes</span>&#8221;) and $750,000,000 in aggregate principal amount of its 5.600% senior
notes due 2055 (the &#8220;<span style="text-decoration: underline">2055 Notes</span>&#8221; and, together with the 2028 Notes, the 2030 Notes and the 2035 Notes, the &#8220;<span style="text-decoration: underline">Notes</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The offering of each series of Notes was registered
under the Securities Act of 1933, as amended (the &#8220;<span style="text-decoration: underline">Act</span>&#8221;), pursuant to AbbVie&#8217;s registration statement on Form&#160;S-3ASR
(File No.&#160;333-284980) (the &#8220;<span style="text-decoration: underline">Registration Statement</span>&#8221;) dated as of February&#160;14, 2025. The terms of the Notes
are further described in AbbVie&#8217;s prospectus supplement dated February&#160;18, 2025, as filed with the Securities and Exchange
Commission pursuant to Rule&#160;424(b)(5)&#160;of the Act on February&#160;20, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Notes are governed by the Indenture, dated
November&#160;8, 2012 (the &#8220;<span style="text-decoration: underline">Base Indenture</span>&#8221;), between AbbVie and U.S. Bank Trust Company, National Association, as
successor-in-interest to U.S. Bank National Association, as trustee (the &#8220;<span style="text-decoration: underline">Trustee</span>&#8221;), as supplemented by that certain
Supplemental Indenture No.&#160;11, dated as of February&#160;26, 2025, with respect to the Notes (the &#8220;<span style="text-decoration: underline">Supplemental Indenture</span>&#8221;
and, together with the Base Indenture as so supplemented, the &#8220;<span style="text-decoration: underline">Indenture</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each series of Notes will mature on March&#160;15
of the applicable year. The Notes are unsecured, unsubordinated obligations of AbbVie and will rank equally in right of payment with all
of AbbVie&#8217;s existing and future unsecured, unsubordinated indebtedness, liabilities and other obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">AbbVie may optionally redeem (i)&#160;the 2028
Notes in whole or in part at any time prior to February&#160;15, 2028 (the &#8220;<span style="text-decoration: underline">2028 Par Call Date</span>&#8221;)&#894; (ii)&#160;the
2030 Notes in whole or in part at any time prior to February&#160;15, 2030 (the &#8220;<span style="text-decoration: underline">2030 Par Call Date</span>&#8221;)&#894; (iii)&#160;the
2035 Notes in whole or in part at any time prior to December&#160;15, 2034 (the &#8220;<span style="text-decoration: underline">2035 Par Call Date</span>&#8221;)&#894; and (iv)&#160;the
2055 Notes in whole or in part at any time prior to September&#160;15, 2054 (the &#8220;<span style="text-decoration: underline">2055 Par Call Date</span>&#8221; and, together
with the 2028 Par Call Date, the 2030 Par Call Date and the 2035 Par Call Date, collectively, the &#8220;<span style="text-decoration: underline">Par Call Dates</span>&#8221;),
each at a redemption price calculated in a manner set forth in the Indenture. On or after the applicable Par Call Date in respect of a
series of Notes, AbbVie may redeem the Notes of such series, in whole or in part, at any time and from time to time, at a redemption price
equal to 100% of the principal amount of the Notes of such series being redeemed plus accrued and unpaid interest thereon to but not including
the redemption date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Indenture contains customary terms and covenants,
including limitations on AbbVie&#8217;s ability and the ability of certain of its subsidiaries to incur liens securing funded indebtedness
and on AbbVie&#8217;s ability to consolidate or merge with or into, or convey, transfer or lease its properties and assets substantially
as an entirety to any person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The foregoing summary of the Indenture does not
purport to be complete and is qualified in its entirety by reference to the full text of the Base Indenture and the Supplemental Indenture,
which are attached as Exhibits 4.1 and 4.2, respectively, hereto and are incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in; text-align: left"><b>Item 9.01.</b></td><td style="text-align: justify"><b>Financial Statements and Exhibits.</b></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;<span style="text-decoration: underline">Exhibits</span>. The following exhibits are provided as part
of this Form&#160;8-K:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in"><a href="https://www.sec.gov/Archives/edgar/data/1551152/000104746912010673/a2211869zex-4_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></a></td>
    <td><a href="https://www.sec.gov/Archives/edgar/data/1551152/000104746912010673/a2211869zex-4_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indenture, dated November&#160;8, 2012, between AbbVie Inc. and U.S. Bank Trust Company, National Association, as trustee (incorporated by reference to Exhibit&#160;4.1 of Amendment No.&#160;5 to AbbVie&#8217;s Registration Statement on Form&#160;10 filed November&#160;16, 2012).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm255723d7_ex4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></a></td>
    <td><a href="tm255723d7_ex4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplemental Indenture No.&#160;11, dated February&#160;26, 2025, between AbbVie Inc. and U.S. Bank Trust Company, National Association, as trustee.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm255723d7_ex4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></a></td>
    <td><a href="tm255723d7_ex4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of 4.650% Note due 2028 (included in Exhibit&#160;4.2 hereto).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm255723d7_ex4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></a></td>
    <td><a href="tm255723d7_ex4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of 4.875% Note due 2030 (included in Exhibit&#160;4.2 hereto).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm255723d7_ex4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</span></a></td>
    <td><a href="tm255723d7_ex4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of 5.200% Note due 2035 (included in Exhibit&#160;4.2 hereto).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm255723d7_ex4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</span></a></td>
    <td><a href="tm255723d7_ex4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of 5.600% Note due 2055 (included in Exhibit&#160;4.2 hereto).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm255723d7_ex5-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></a></td>
    <td><a href="tm255723d7_ex5-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Wachtell, Lipton, Rosen&#160;&amp; Katz, dated February&#160;26, 2025, with respect to the Notes.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm255723d7_ex5-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></a></td>
    <td><a href="tm255723d7_ex5-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Wachtell, Lipton, Rosen&#160;&amp; Katz (included in Exhibit&#160;5.1 of this Current Report on Form&#160;8-K)</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page&#160;Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-size: 10pt">&#160;</span></td>
<td colspan="2" style="padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-size: 10pt"><b>ABBVIE INC.</b></span></td></tr>
<tr style="vertical-align: top">
<td style="width: 50%; padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-size: 10pt">&#160;</span></td>
<td style="width: 3%; padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-size: 10pt">&#160;</span></td>
<td style="width: 47%; padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-size: 10pt">&#160;</span></td>
</tr>
<tr style="vertical-align: top">
<td style="padding-right: 0.25pt; padding-left: 0.25pt; font-size: 10pt"><span style="font-size: 10pt">Date: February 26, 2025</span></td>
<td style="padding-right: 0.25pt; padding-left: 0.25pt; font-size: 10pt"><span style="font-size: 10pt">By:</span></td>
<td style="border-bottom: black 1pt solid; padding-right: 0.25pt; padding-left: 0.25pt; font-size: 10pt"><span style="font-size: 10pt">/s/ Scott
T. Reents</span></td>
</tr>
<tr style="vertical-align: top">
<td style="padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-size: 10pt">&#160;</span></td>
<td style="padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-size: 10pt">&#160;</span></td>
<td style="padding-right: 0.25pt; padding-left: 0.25pt; font-size: 10pt"><span style="font-size: 10pt">Scott T. Reents</span></td>
</tr>
<tr style="vertical-align: top">
<td style="padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-size: 10pt">&#160;</span></td>
<td style="padding-right: 0.25pt; padding-left: 0.25pt"><span style="font-size: 10pt">&#160;</span></td>
<td style="white-space: nowrap; padding-right: 0.25pt; padding-left: 0.25pt; font-size: 10pt"><span style="font-size: 10pt">Executive Vice President, Chief Financial
Officer</span></td>
</tr>
</table>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjUEKwjAQRU/QOwxZi02D3XRpqSJWkSLiNthRgm2mTKK2R/KWxhZxGBiG/9//QszEmlamQYbzsirhiG3XaI9Q4RUZ7QWDI99sMwi3wptxnrX14/sDcwoMBiadq1QHYbQ+jcM6A6liuYhVCjLJUgWHnYi+ek72amq03ugGtK3hwNSxQa95mBKOuidL7TBWnZCdIZtBMpeT/AYlEwV7euoX8d1BWeYimo0TiTXTowuuovdovyQUDbahzk30f6MPBT5Kig== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>tm255723d7_ex4-2.htm
<DESCRIPTION>EXHIBIT 4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ABBVIE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SUPPLEMENTAL INDENTURE NO. 11</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,250,000,000 4.650% Senior Notes due 2028<BR>
$1,000,000,000 4.875% Senior Notes due 2030<BR>
$1,000,000,000 5.200% Senior Notes due 2035<BR>
$750,000,000 5.600% Senior Notes due 2055</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">THIS SUPPLEMENTAL INDENTURE NO. 11, dated as of
February&nbsp;26, 2025 (the &ldquo;<B>Supplemental Indenture</B>&rdquo;), among ABBVIE INC., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;),
and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, a national banking association, as successor-in-interest to U.S. Bank National Association,
as trustee (the &ldquo;<B>Trustee</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">RECITALS OF THE COMPANY:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Company has heretofore executed and
delivered to the Trustee an Indenture, dated as of November&nbsp;8, 2012 (as heretofore supplemented or amended, the &ldquo;<B>Indenture</B>&rdquo;),
providing for the issuance from time to time of one or more series of Securities (as defined in the Indenture);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, Article&nbsp;IX of the Indenture provides
for various matters with respect to any series of Securities issued under the Indenture to be established in an indenture supplemental
to the Indenture;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, Section&nbsp;9.1(7)&nbsp;of the Indenture
provides that the Company and the Trustee may enter into an indenture supplemental to the Indenture to establish the form or terms of
Securities of any series as permitted by Sections 2.1 and 3.1 of the Indenture; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, all the conditions and requirements necessary
to make this Supplemental Indenture, when duly executed and delivered, a valid and binding agreement in accordance with its terms and
for the purposes herein expressed have been performed and fulfilled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOW THEREFORE, THIS SUPPLEMENTAL INDENTURE WITNESSETH:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For and in consideration of the premises and the
issuance of the series of Securities provided for herein, the Company and the Trustee mutually covenant and agree for the equal and proportionate
benefit of the respective Holders of the Securities of each such series as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article&nbsp;1.</FONT><BR>
RELATION TO INDENTURE; DEFINITIONS; RULES OF CONSTRUCTION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Relation
to Indenture</I>.&nbsp; This Supplemental Indenture constitutes an integral part of the Indenture and capitalized terms defined in the
Indenture that are used but not defined herein shall have the meanings assigned to such terms in the Indenture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Definitions</I>.&nbsp;
For all purposes of this Supplemental Indenture, the following terms shall have the respective meanings set forth in this Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B>2028 Notes</B>&rdquo; has the meaning
assigned to such term in <U>Section&nbsp;2.1</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B>2030 Notes</B>&rdquo; has the meaning
assigned to such term in <U>Section&nbsp;2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B>2035 Notes</B>&rdquo; has the meaning
assigned to such term in <U>Section&nbsp;2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B>2055 Notes</B>&rdquo; has the meaning
assigned to such term in <U>Section&nbsp;2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B>Definitive Note</B>&rdquo; means a certificated
Note that does not include the Global Notes Legend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B>Depository</B>&rdquo; means The Depository
Trust Company, its nominees and their respective successors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B>Global Notes Legend</B>&rdquo; means
the legend set forth in Exhibits A1 through A4 to this Supplemental Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B>Notes</B>&rdquo; means the 2028 Notes,
the 2030 Notes, the 2035 Notes and the 2055 Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B>Notes Custodian</B>&rdquo; means the
custodian with respect to a Global Note (as appointed by the Depository) or any successor person thereto, who will initially be the Trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B>Participant</B>&rdquo; means members
of, or participants in, the Depository.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Amendment
to Section&nbsp;4.1 of the Indenture</I>.&nbsp; Solely as it relates to the Notes, Section&nbsp;4.1 of the Indenture shall be amended
by replacing subsection (1)(B)&nbsp;with the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(B)</TD><TD>all of the Securities of such series not theretofore delivered to the Trustee for cancellation</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">have
become due and payable,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">will
become due and payable at their Stated Maturity within one year, or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">if
redeemable at the Company&rsquo;s option, are to be called for redemption within one year under arrangements satisfactory to the Trustee
for the giving of notice of redemption by the Trustee in the name, and at the expense, of the Company,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">and the Company, in the case of clause&nbsp;(i), (ii)&nbsp;or
(iii)&nbsp;above, has irrevocably deposited or caused to be deposited with the Trustee funds in an amount sufficient to pay and discharge
the entire indebtedness on the Securities of such series not theretofore delivered to the Trustee for cancellation, for principal of,
premium, if any, and interest on the Securities of such series to the date of such deposit (in the case of Securities which have become
due and payable), or to their Stated Maturity or the Redemption Date, as the case may be (provided that in connection with any discharge
relating to any redemption that requires the payment of a premium, the amount deposited shall be sufficient for purposes of the Indenture
to the extent that an amount is deposited with the Trustee equal to the premium calculated as of the date of the notice of redemption,
with any deficit as of the Redemption Date only required to be deposited with the Trustee on or prior to the Redemption Date), together
with irrevocable instructions from the Company directing the Trustee to apply such funds to the payment thereof at Maturity or the Redemption
Date, as the case may be;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Amendment
to Section&nbsp;5.1 to the Indenture</I>. Solely as it relates to the Notes, Section&nbsp;5.1 of the Indenture shall be amended by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">replacing
subsection (4)&nbsp;with the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;default
in the performance, or breach, of any covenant or warranty of the Company in this </FONT>Indenture (other than a covenant or warranty
a default in whose performance or whose breach is elsewhere in this Section&nbsp;specifically dealt with or which has expressly been included
in this Indenture solely for the benefit of series of Securities other than that series), and continuance of such default or breach for
a period of 90 days after the giving of written notice to the Company by the Trustee or to the Company and the Trustee by the Holders
of at least 25% in principal amount of the Outstanding Securities of that series a written notice specifying such default or breach and
requiring it to be remedied and stating that such notice is a &ldquo;Notice of Default&rdquo; hereunder (provided that such notice may
not be given with respect to any action taken, and reported publicly or to Holders of the Securities more than two years prior to such
notice)&#894;&rdquo; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">adding
the following paragraph at the end of Section&nbsp;5.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&ldquo;Any time period in this Indenture to cure any actual
or alleged default or Event of Default may be extended or stayed by a court of competent jurisdiction.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.5</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Amendment
to Section&nbsp;11.2 of the Indenture</I>.&nbsp; Solely as it relates to the Notes, Section&nbsp;11.2 of the Indenture shall be amended
by replacing &ldquo;45 days&rdquo; with &ldquo;15 days&rdquo; therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.6</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Amendment
to Section&nbsp;11.3 of the Indenture</I>.&nbsp;Solely as it relates to the Notes, Section&nbsp;11.3 of the Indenture shall be amended
by (a)&nbsp;replacing &ldquo;45 days&rdquo; with &ldquo;15 days&rdquo; therein, in each instance thereof, and (b)&nbsp;replacing &ldquo;by
random lot&rdquo; with &ldquo;pro rata, by lot or by such other method as the Trustee in its sole discretion deems appropriate and fair.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.7</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Amendment
to Section&nbsp;11.4 of the Indenture</I>.&nbsp;Solely as it relates to the Notes, Section&nbsp;11.4 of the Indenture shall be amended
by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">replacing
the first sentence therein with the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;</FONT>Notice
of redemption shall be given electronically or by first-class mail, postage prepaid to each Holder of Securities to be redeemed, at his
or her address appearing in the Security Register, or otherwise in accordance with the applicable procedures of The Depository Trust Company,
sent or mailed not less than 10 nor more than 60 days prior to the Redemption Date.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">adding
the following sentence to the end of Section&nbsp;11.4 of the Indenture:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;Any
redemption or notice of redemption may, at the Company&rsquo;s discretion, be subject to one or more conditions precedent, and, at the
Company&rsquo;s discretion, the redemption date may be delayed until such time as any or all </FONT>such conditions shall be satisfied.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.8</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Amendment
to Section&nbsp;13.4 of the Indenture</I>.<I>&nbsp;</I>Solely as it relates to the Notes, Section&nbsp;13.4 of the Indenture shall be
amended by replacing subsections (5)&nbsp;and (6)&nbsp;with the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(5)</TD><TD>In the case of an election under Section&nbsp;13.2, the Company shall have delivered to the Trustee an Opinion of Counsel stating
that (x)&nbsp;the Company has received from, or there has been published by, the Internal Revenue Service a ruling, or (y)&nbsp;since
the date of this Indenture there has been a change in the applicable Federal income tax law, in either case to the effect that, and based
thereon such opinion shall confirm that, the beneficial owners of the Outstanding Securities of such series will not recognize income,
gain or loss for Federal income tax purposes as a result of such defeasance and will be subject to Federal income tax in the same manner
as would have been the case if such defeasance had not occurred.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(6)</TD><TD>In the case of an election under Section&nbsp;13.3, the Company shall have delivered to the Trustee an Opinion of Counsel to the effect
that the beneficial owners of the Outstanding Securities of such series will not recognize income, gain or loss for Federal income tax
purposes as a result of such covenant defeasance and will be subject to Federal income tax in the same manner as would have been the case
if such covenant defeasance had not occurred.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.9</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Rules&nbsp;of
Construction</I>.&nbsp; For all purposes of this Supplemental Indenture:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">capitalized
terms used herein without definition shall have the meanings specified in the Indenture;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">all
references herein to Articles and Sections, unless otherwise specified, refer to the corresponding Articles and Sections of this Supplemental
Indenture;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
terms &ldquo;herein,&rdquo; &ldquo;hereof,&rdquo; &ldquo;hereunder&rdquo; and other words of similar import refer to this Supplemental
Indenture; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">in
the event of a conflict with the definition of terms in the Indenture, the definitions in this Supplemental Indenture shall control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article&nbsp;2.</FONT><BR>
THE SECURITIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Title
of the Notes</I>.&nbsp; There shall be (i)&nbsp;a series of Securities designated the 4.650% Senior Notes due 2028 (the &ldquo;<B>2028
Notes</B>&rdquo;), (ii)&nbsp;a series of Securities designated the 4.875% Senior Notes due 2030 (the &ldquo;<B>2030 Notes</B>&rdquo;),
(iii)&nbsp;a series of Securities designated the 5.200% Senior Notes due 2035 (the &ldquo;<B>2035 Notes</B>&rdquo;) and (iv)&nbsp;a series
of Securities designated the 5.600% Senior Notes due 2055 (the &ldquo;<B>2055 Notes</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Initial
Principal Amount</I>.&nbsp; The 2028 Notes will be initially issued in an aggregate principal amount of $1,250,000,000, the 2030 Notes
will be initially issued in an aggregate principal amount of $1,000,000,000, the 2035 Notes will be initially issued in an aggregate principal
amount of $1,000,000,000 and the 2055 Notes will be initially issued in an aggregate principal amount of $750,000,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">[<I>Reserved</I>].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Form&nbsp;and
Dating</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>General</I>.&nbsp;
The Notes and the Trustee&rsquo;s certificate of authentication shall be substantially in the forms set forth in the corresponding Exhibits&nbsp;A1-A4
hereto. The Notes may have notations, legends or endorsements required by law, stock exchange rule&nbsp;or usage. Each Note shall be dated
the date of its authentication. The Notes shall be in denominations of $2,000 and integral multiples of $1,000 in excess thereof. The
Notes of each series and any additional Notes of such series subsequently issued under the Indenture will be treated as a single series
or class for all purposes under the Indenture, including, without limitation, waivers, amendments and redemptions; provided that, if any
such additional Notes are not fungible with the existing Notes for Federal income tax purposes, such additional Notes will have a separate
CUSIP number.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The terms and provisions contained in the Notes
shall constitute, and are hereby expressly made, a part of this Supplemental Indenture, and the Company and the Trustee, by their execution
and delivery of this Supplemental Indenture, expressly agree to such terms and provisions and to be bound thereby. However, to the extent
any provision of any Note conflicts with the express provisions of this Supplemental Indenture, the provisions of this Supplemental Indenture
shall govern and be controlling.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company hereby designates The Depository Trust
Company as the initial Depository for the Global Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Global
Notes</I>.&nbsp; The Notes will be issued initially in the form of one or more global notes (the &ldquo;<B>Global Notes</B>&rdquo;) in
definitive, fully registered, book-entry form. The Global Notes will be delivered to the Notes Custodian and registered in the name of
the Depository or the nominee of such Depository. The aggregate principal amount of the Global Notes may from time to time be increased
or decreased by adjustments made on the records of the Trustee and the Depository or its nominee as hereinafter provided.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Book-Entry
Provisions</I>.&nbsp; This Section&nbsp;2.4(c)&nbsp;shall apply only to a Global Note deposited with or on behalf of the Depository. The
Company shall execute and the Trustee shall, in accordance with this Section&nbsp;2.4(c)&nbsp;and pursuant to an order of the Company,
authenticate and deliver initially one or more Global Notes that (A)&nbsp;shall be registered in the name of the Depository for such Global
Note or Global Notes or the nominee of such Depository and (B)&nbsp;shall be delivered by the Trustee to such Depository or pursuant to
such Depository&rsquo;s instructions or held by the Trustee as Notes Custodian.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Payments</I>.&nbsp;
Payments in respect of the principal of, premium, if any, and interest on a Global Note registered in the name of the Depository or its
nominee will be payable to the Depository in its capacity as the registered holder under the Indenture. Under the terms of the Indenture,
the Company, the Trustee and any agent of the Company or the Trustee will treat the persons in whose names the Notes, including the Global
Notes, are registered as the owners of the Notes for the purpose of receiving payments and for all other purposes, whether or not the
Notes be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary. Notwithstanding
the foregoing, nothing herein shall prevent the Company, the Trustee or any agent of the Company or the Trustee from giving effect to
any written certification, proxy or other authorization furnished by the Depository or impair, as between the Depository and its Participants,
the operation of customary practices of such Depository governing the exercise of the rights of a holder of a beneficial interest in any
Global Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Definitive
Notes</I>.&nbsp; Except as provided in Section&nbsp;2.6, owners of a beneficial interest in the Global Notes will not have Notes registered
in their names, will not receive physical delivery of Definitive Notes and will not be considered the registered owners or &ldquo;holders&rdquo;
thereof under the Indenture for any purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.5</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Transfer
and Exchange</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Transfer
and Exchange of Definitive Notes</I>.&nbsp; When Definitive Notes are presented to the Security Registrar with a request:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">to
register the transfer of such Definitive Notes; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">to
exchange such Definitive Notes for an equal principal amount of Definitive Notes of other authorized denominations, the Security Registrar
shall register the transfer or make the exchange as requested if its reasonable requirements for such transaction are met; provided, however,
that the Definitive Notes surrendered for transfer or exchange:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">shall
be duly endorsed or accompanied by a written instrument of transfer in form reasonably satisfactory to the Company and the Security Registrar,
duly executed by the Holder thereof or his or her attorney duly authorized in writing; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">are
accompanied by the following additional information and documents, as applicable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">if
such Definitive Notes are being delivered to the Security Registrar by a Holder for registration in the name of such Holder, without transfer,
a certification from such Holder to that effect (in the form set forth on the reverse side of the Note); or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">if
such Definitive Notes are being transferred to the Company, a certification to that effect (in the form satisfactory to the Trustee).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Restrictions
on Transfer of a Definitive Note for a Beneficial Interest in a Global Note</I>.&nbsp; A Definitive Note may not be exchanged for a beneficial
interest in a Global Note except upon satisfaction of the requirement set forth below. Upon receipt by the Trustee of a Definitive Note,
duly endorsed or accompanied by a written instrument of transfer in form reasonably satisfactory to the Company and the Security Registrar,
together with written instructions directing the Trustee to make, or to direct the Notes Custodian to make, an adjustment on its books
and records with respect to such Global Note to reflect an increase in the aggregate principal amount of the Notes represented by the
Global Note, such instructions to contain information regarding the Depository account to be credited with such increase, then the Trustee
shall cancel such Definitive Note and cause, or direct the Notes Custodian to cause, in accordance with the standing instructions and
procedures existing between the Depository and the Notes Custodian, the aggregate principal amount of Notes represented by the Global
Note to be increased by the aggregate principal amount of the Definitive Note to be exchanged and shall credit or cause to be credited
to the account of the Person specified in such instructions a beneficial interest in the Global Note equal to the principal amount of
the Definitive Note so canceled. If no Global Notes are then outstanding and the Global Note has not been previously exchanged for certificated
securities pursuant to Section&nbsp;2.6, the Company shall issue and the Trustee shall authenticate, upon receipt of a Company Order,
a new Global Note in the appropriate principal amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Transfer
and Exchange of Global Notes</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
transfer and exchange of Global Notes or beneficial interests therein shall be effected through the Depository, in accordance with this
Supplemental Indenture (including applicable restrictions on transfer set forth herein, if any) and the procedures of the Depository therefor.
A transferor of a beneficial interest in a Global Note shall deliver a written order given in accordance with the Depository&rsquo;s procedures
containing information regarding the participant account of the Depository to be credited with a beneficial interest in such Global Note
or another Global Note, and such account shall be credited in accordance with such order with a beneficial interest in the applicable
Global Note, and the account of the Person making the transfer shall be debited by an amount equal to the beneficial interest in the Global
Note being transferred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
the proposed transfer is a transfer of a beneficial interest in one Global Note to a beneficial interest in another Global Note, the Security
Registrar shall reflect on its books and records the date and an increase in the principal amount of the Global Note to which such interest
is being transferred in an amount equal to the principal amount of the interest to be so transferred, and the Security Registrar shall
reflect on its books and records the date and a corresponding decrease in the principal amount of the Global Note from which such interest
is being transferred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Notwithstanding
any other provisions of this Supplemental Indenture (other than the provisions set forth in Section&nbsp;2.6), a Global Note may not be
transferred as a whole except by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or
another nominee of the Depository or by the Depository or any such nominee to a successor Depository or a nominee of such successor Depository.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">[<I>Reserved</I>].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">[<I>Reserved</I>].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Cancellation
or Adjustment of Global Note</I>. At such time as all beneficial interests in a Global Note have either been exchanged for Definitive
Notes, transferred, redeemed, repurchased or canceled, such Global Note shall be returned by the Depository to the Trustee for cancellation
or retained and canceled by the Trustee. At any time prior to such cancellation, if any beneficial interest in a Global Note is exchanged
for Definitive Notes, transferred in exchange for an interest in another Global Note, redeemed, repurchased or canceled, the principal
amount of Notes represented by such Global Note shall be reduced, and an adjustment shall be made on the books and records of the Trustee
(if it is then the Notes Custodian for such Global Note) with respect to such Global Note, by the Trustee or the Notes Custodian, to reflect
such reduction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Obligations
with Respect to Transfers and Exchanges of Notes</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">To
permit registrations of transfers and exchanges, the Company shall execute and the Trustee shall authenticate, Definitive Notes and Global
Notes at the Security Registrar&rsquo;s request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
service charge shall be made for any registration of transfer or exchange of the Notes, but the Company or the Security Registrar may
require payment of a sum sufficient to cover any transfer tax, assessments, or similar governmental charge payable in connection therewith
(other than any such transfer taxes, assessments or similar governmental charge payable upon exchange or transfer pursuant to Sections
9.6 or 11.7 of the Indenture).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Prior
to the due presentation for registration of transfer of any Note, the Company, the Trustee, the Paying Agent or the Security Registrar
may deem and treat the person in whose name a Note is registered as the absolute owner of such Note for the purpose of receiving payment
of principal of and interest on such Note and for all other purposes whatsoever, whether or not such Note is overdue, and none of the
Company, the Trustee, the Paying Agent or the Security Registrar shall be affected by notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company hereby appoints the Trustee as Security Registrar for the Notes. Neither the Company nor the Security Registrar shall be required
to register the transfer of or exchange Notes of any series (i)&nbsp;during a period beginning at the opening of business 15 days before
the day of the mailing of a notice of redemption of Notes of that series selected for redemption under Section&nbsp;11.3 of the Indenture
and ending at the close of business on the day of such mailing, or (ii)&nbsp;so selected for redemption in whole or in part, except the
unredeemed portion of any Note being redeemed in part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">All
Notes issued upon any transfer or exchange pursuant to the terms of this Supplemental Indenture shall evidence the same Debt and shall
be entitled to the same benefits under the Indenture as the Notes surrendered upon such transfer or exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>No
Obligation of the Trustee</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Trustee shall have no responsibility or obligation to any beneficial owner of a Global Note, a member of, or a participant in, the Depository
or any other Person with respect to the accuracy of the records of the Depository or its nominee or of any participant or member thereof,
with respect to any ownership interest in the Notes or with respect to the delivery to any participant, member, beneficial owner or other
Person (other than the Depository) of any notice (including any notice of redemption or repurchase) or the payment of any amount, under
or with respect to such Notes. All notices and communications to be given to the Holders and all payments to be made to Holders under
the Notes shall be given or made only to the registered Holders (which shall be the Depository or its nominee in the case of a Global
Note). The rights of beneficial owners in any Global Note shall be exercised only through the Depository subject to the applicable rules&nbsp;and
procedures of the Depository. The Trustee may rely and shall be fully protected in relying upon information furnished by the Depository
with respect to its members, participants and any beneficial owners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Trustee shall have no obligation or duty to monitor, determine or inquire as to compliance with any restrictions on transfer imposed under
this Supplemental Indenture or under applicable law with respect to any transfer of any interest in any Note (including any transfers
between or among Depository participants, members or beneficial owners in any Global Note) other than to require delivery of such certificates
and other documentation or evidence as are expressly required by, and to do so if and when expressly required by, the terms of this Supplemental
Indenture, and to examine the same to determine substantial compliance as to form with the express requirements hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.6</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Definitive
Notes</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">A
Global Note deposited with the Depository or with the Trustee as Notes Custodian pursuant to Section&nbsp;2.4 shall be transferred to
the beneficial owners thereof in the form of Definitive Notes in an aggregate principal amount equal to the principal amount of such Global
Note, in exchange for such Global Note, only if such transfer complies with Section&nbsp;2.5 and (i)&nbsp;the Depository (A)&nbsp;notifies
the Company that the Depository is no longer willing or able to act as a depositary or clearing system for the Notes or (B)&nbsp;ceases
to be a &ldquo;clearing agency&rdquo; registered under the Securities Exchange Act of 1934, as amended, and in either event, a successor
depositary or clearing system is not appointed by the Company within 90 days of such notice or cessation, (ii)&nbsp;upon the occurrence
and continuation of an Event of Default and the Depository notifies the Trustee of its decision to exchange the Global Note for Definitive
Notes, or (iii)&nbsp;the Company determines not to have the Notes represented by a Global Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
Global Note that is transferable to the beneficial owners thereof pursuant to this Section&nbsp;2.6 shall be surrendered by the Depository
to the Trustee, to be so transferred, in whole or from time to time in part, without charge, and upon Company Order the Trustee shall
authenticate and deliver, upon such transfer of each portion of such Global Note, an equal aggregate principal amount of Definitive Notes
of authorized denominations. Any portion of a Global Note transferred pursuant to this Section&nbsp;2.6 shall be executed, authenticated
and delivered only in denominations of $2,000 of principal amount and any integral multiple of $1,000 in excess thereof and registered
in such names as requested by or on behalf of the Depository (in accordance with its customary procedures).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
registered Holder of a Global Note may grant proxies and otherwise authorize any Person, including Participants and Persons that may hold
interests through Participants, to take any action which a Holder is entitled to take under the Indenture or the Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
the event of the occurrence of any of the events specified in Section&nbsp;2.6(a)(i), (ii)&nbsp;or (iii), the Company will promptly make
available to the Trustee a reasonable supply of Definitive Notes in fully registered form without interest coupons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article&nbsp;3.</FONT><BR>
MISCELLANEOUS PROVISIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Ratification</I>.&nbsp;
The Indenture, as supplemented and amended by this Supplemental Indenture, is in all respects hereby adopted, ratified and confirmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Counterparts</I>.&nbsp;
This Supplemental Indenture may be executed in any number of counterparts, each of which when so executed shall be deemed an original,
and all such counterparts shall together constitute but one and the same instrument. The exchange of copies of this Supplemental Indenture
and of signature pages&nbsp;by facsimile, PDF or other electronic transmission shall constitute effective execution and delivery of this
Supplemental Indenture as to the parties hereto and may be used in lieu of the original Supplemental Indenture for all purposes. Signatures
of the parties hereto transmitted by facsimile, PDF or other electronic transmission (e.g., www.docusign.com) shall constitute effective
execution and delivery of this Supplemental Indenture as to the other parties hereto shall be deemed to be their original signatures for
all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The words &ldquo;execution,&rdquo; &ldquo;signed,&rdquo; &ldquo;signature,&rdquo;
and words of like import in this Supplemental Indenture and (solely as it relates to the Notes) in the Indenture shall be deemed to include
electronic signatures or electronic records, each of which shall be of the same legal effect, validity or enforceability as a manually
executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable
law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records
Act, or any other similar state laws based on the Uniform Electronic Transactions Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company agrees to assume all risks arising out of the use of digital
signatures and electronic methods to submit communications to the Trustee, including without limitation the risk of the Trustee acting
on unauthorized instructions, and the risk of interception and misuse by third parties, in each case, except to the extent arising from
the negligence or bad faith of the Trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Governing
Law</I>.&nbsp; THIS SUPPLEMENTAL INDENTURE AND EACH NOTE SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF
NEW YORK.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Conflict
with Trust Indenture Act</I>.&nbsp; If any provision hereof limits, qualifies or conflicts with a provision of the Trust Indenture Act
that is required under the Trust Indenture Act to be a part of and govern this Supplemental Indenture, the latter provision shall control.
If any provision of this Supplemental Indenture modifies or excludes any provision of the Trust Indenture Act that may be so modified
or excluded, the latter provision shall be deemed to apply to this Supplemental Indenture as so modified or to be excluded, as the case
may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.5</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>The
Trustee</I>.&nbsp; The recitals contained herein and in the Securities, except the Trustee&rsquo;s certificates of authentication, shall
be taken as the statements of the Company, and the Trustee assumes no responsibility for their correctness.&nbsp; The Trustee makes no
representations as to the validity or sufficiency of this Supplemental Indenture or of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature pages&nbsp;follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Supplemental Indenture to be duly executed as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">ABBVIE INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/
Scott T. Reents</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 42%"><FONT STYLE="font-size: 10pt">Scott T. Reents</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Executive Vice President, Chief Financial Officer</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[<I>Signature Page&nbsp;to Supplemental Indenture</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    BANK TRUST COMPANY, NATIONAL ASSOCIATION, <BR>
    as Trustee</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Linda Garcia</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Linda Garcia</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 42%">Vice President</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Supplemental Indenture</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;A1 &mdash; Form&nbsp;of 4.650%
Senior Notes due 2028</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ABBVIE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>4.650% Senior Notes due 2028</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%; font: bold 10pt Times New Roman, Times, Serif; text-align: left">No.&nbsp;[&bull;]</TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; width: 49%; font: bold 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$[&bull;]</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CUSIP No: 00287Y DY2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ISIN No: US00287YDY23</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Security is a Security in a global form within
the meaning of the Indenture hereinafter referred to and is registered in the name of the Depository or a nominee of the Depository. This
global Security is exchangeable for Securities registered in the name of a Person other than the Depository or its nominee only in the
limited circumstances described in the Indenture, and no transfer of this Security (other than a transfer of this Security as a whole
by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or another nominee of the Depository)
may be registered except in such limited circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless this Security is presented by an authorized
representative of The Depository Trust Company to the issuer or its agent for registration of transfer, exchange or payment, and any Security
issued upon registration of transfer of, or in exchange for, or in lieu of, this Security is registered in the name of Cede&nbsp;&amp;
Co. or such other name as requested by an authorized representative of The Depository Trust Company and any payment hereon is made to
Cede&nbsp;&amp; Co., ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL since&nbsp;the registered
owner hereof, Cede&nbsp;&amp; Co., has an interest herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ABBVIE INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ABBVIE
INC., a corporation duly organized and existing under the laws of Delaware (herein called the &ldquo;<U>Company</U>,&rdquo; which term
includes any successor Person under the Indenture and Supplemental Indenture hereinafter referred to), for value received, hereby promises
to pay to Cede&nbsp;&amp; Co., as nominee for The Depository Trust Company, or registered assigns, the principal sum of [<B>&bull;</B></FONT>]
Dollars ($[<FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&bull;</B></FONT>]), or such other principal sum as may be indicated
on the Schedule of Exchanges attached hereto, on March&nbsp;15, 2028 and to pay interest thereon from February&nbsp;26, 2025 or from the
most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually in arrears on March&nbsp;15 and
September&nbsp;15 in each year, commencing September&nbsp;15, 2025, at the rate of 4.650% per annum, until the principal hereof is paid
or made available for payment. The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as
provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at
the close of business on the Regular Record Date for such interest, which shall be the date that is fifteen calendar days prior to the
relevant Interest Payment Date (whether or not a Business Day). Any such interest not so punctually paid or duly provided for will forthwith
cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Security (or one
or more Predecessor Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest
to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such
Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange
on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided
in said Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Payment of the principal of (and premium, if any)
and any such interest on this Security will be made at the office or agency of the Company maintained for that purpose in St. Paul, Minnesota,
in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts;
provided, however, that at the option of the Company payment of interest may be made by (1)&nbsp;check mailed to the address of the Person
entitled thereto as such address shall appear in the Security Register or (2)&nbsp;wire transfer as directed by the Holder, in immediately
available funds to an account maintained by the Depository or its nominee with respect to a Global Note, and to the Holder or its nominee
with respect to a Definitive Note; provided further that in the case of a Definitive Note (1)&nbsp;the Holder thereof shall have provided
written wiring instructions to the Trustee on or before the related Regular Record Date and (2)&nbsp;if appropriate instructions for any
such wire transfer are not received by the related Regular Record Date, then such payment shall be made by check mailed to the address
of the Holder specified in the Security Register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Reference is hereby made to the further provisions
of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same effect as if set forth
at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless the certificate of authentication hereon
has been executed by the Trustee referred to herein by manual signature, this Security shall not be entitled to any benefit under the
Indenture or be valid or obligatory for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the Company has caused this
instrument to be duly executed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: February&nbsp;26, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">ABBVIE INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 42%"><FONT STYLE="font-size: 10pt">Scott T. Reents</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Chief Financial Officer and Executive Vice President</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TRUSTEE&rsquo;S CERTIFICATE OF AUTHENTICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This is one of the Securities of the series designated
therein referred to in the within-mentioned Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: February&nbsp;26, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">U.S.
    BANK TRUST COMPANY, NATIONAL ASSOCIATION,<BR> as Trustee</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 42%"><FONT STYLE="font-size: 10pt">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">[Authorized Officer]</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[FORM&nbsp;OF REVERSE OF SECURITY]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Security is one of a duly authorized issue
of securities of the Company (herein called the &ldquo;<U>Securities</U>&rdquo;), issued and to be issued in one or more series under
an Indenture, dated as of November&nbsp;8, 2012, as it may be supplemented or amended from time to time (herein called the &ldquo;<U>Indenture</U>&rdquo;),
between the Company and U.S. Bank Trust Company, National Association, as successor-in-interest to U.S. Bank National Association, as
trustee (herein called the &ldquo;<U>Trustee</U>,&rdquo; which term includes any successor trustee under the Indenture), and Supplemental
Indenture No.&nbsp;11, dated as of February&nbsp;26, 2025 (herein called the &ldquo;<U>Supplemental Indenture</U>&rdquo;), among the Company
and the Trustee, to which Indenture, Supplemental Indenture and all indentures supplemental thereto reference is hereby made for a statement
of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Securities
of this series and of the terms upon which the Securities of this series are, and are to be, authenticated and delivered. This Security
is one of the series designated on the face hereof, in an initial aggregate principal amount of $1,250,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At any time prior to the Par Call Date (as defined
below), the Company may redeem the Securities of this series at its option, in whole or in part, at any time and from time to time, at
a Redemption Price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(1)&nbsp;(a)&nbsp;the sum of the present values
of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming such Securities matured
on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 10
basis points, less (b)&nbsp;interest accrued to the date of redemption, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(2)&nbsp;100% of the principal amount of the Securities
of this series to be redeemed,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">plus, in either case, accrued and unpaid interest
thereon to the Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On or after the Par Call Date, the Company may
redeem the Securities of this series, in whole or in part, at any time and from time to time, at a Redemption Price equal to 100% of the
principal amount of the Securities of this series being redeemed plus accrued and unpaid interest thereon to the Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<U>Par
Call Date</U>&rdquo; means February&nbsp;15</FONT>, 2028 (the date that is one (1)&nbsp;month prior to the maturity date of the Securities
of this series).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Treasury Rate</U>&rdquo; means, with
respect to any Redemption Date for Securities of this series, the yield applicable to this series of Securities determined by the Company
in accordance with the following two paragraphs. The Treasury Rate applicable to this series of Securities shall be determined by the
Company after 4:15&nbsp;p.m., New York City time (or after such time as yields on U.S. government securities are posted daily by the Board
of Governors of the Federal Reserve System), on the third New York Business Day preceding such Redemption Date based upon the yield or
yields for the most recent day that appear after such time on such day in the most recent statistical release published by the Board of
Governors of the Federal Reserve System designated as &ldquo;Selected Interest Rates (Daily) &mdash; H.15&rdquo; (or any successor designation
or publication) (&ldquo;H.15&rdquo;) under the caption &ldquo;U.S. government securities &mdash; Treasury constant maturities &mdash;
Nominal&rdquo; (or any successor caption or heading) (&ldquo;H.15 TCM&rdquo;). In determining the applicable Treasury Rate, the Company
shall select, as applicable: (1)&nbsp;the yield for the Treasury constant maturity on H.15 exactly equal to the period from such Redemption
Date to the applicable Par Call Date (the &ldquo;Remaining Life&rdquo;); or (2)&nbsp;if there is no such Treasury constant maturity on
H.15 exactly equal to the Remaining Life, the two yields &mdash; one yield corresponding to the Treasury constant maturity on H.15 immediately
shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life &mdash;
and shall interpolate to the applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields and
rounding the result to three decimal places; or (3)&nbsp;if there is no such Treasury constant maturity on H.15 shorter than or longer
than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this
paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant
number of months or years, as applicable, of such Treasury constant maturity from such redemption date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If on the third New York Business Day preceding
such Redemption Date, H.15 TCM is no longer published, the Company shall calculate the applicable Treasury Rate based on the rate per
annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second New York Business Day preceding
such Redemption Date of the United States Treasury security maturing on, or with a maturity that is closest to, the Par Call Date, as
applicable. If there is no United States Treasury security maturing on the Par Call Date but there are two or more United States Treasury
securities with a maturity date equally distant from the applicable Par Call Date, one with a maturity date preceding the Par Call Date
and one with a maturity date following the Par Call Date, the Company shall select the United States Treasury security with a maturity
date preceding the Par Call Date. If there are two or more United States Treasury securities maturing on the Par Call Date or two or more
United States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among these two or more
United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid
and asked prices for such United States Treasury securities at 11:00 a.m., New York City time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In determining the applicable Treasury Rate in
accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall
be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time,
of such United States Treasury security, and rounded to three decimal places.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company&rsquo;s actions and determinations
in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No Securities of this series of a principal amount
of $2,000 or less will be redeemed in part. For so long as the Securities are held by The Depository Trust Company (or another depositary),
the redemption of the Securities shall be done in accordance with the policies and procedures of the applicable depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>New York Business Day</U>&rdquo; means
any calendar day that is not a Saturday, Sunday or legal holiday in New York, New York and on which commercial banks are open for business
in New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Securities of this series do not provide for
a sinking fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If an Event of Default with respect to Securities
of this series shall occur and be continuing, the principal of the Securities of this series may be declared due and payable in the manner
and with the effect provided in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Indenture contains provisions for defeasance
at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect to this Security,
in each case upon compliance with certain conditions set forth therein. Sections 13.2 and 13.3 of the Indenture apply to the Securities
of this series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Indenture permits, with certain exceptions
as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders
of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with the consent of the
Holders of not less than a majority in principal amount of the Securities at the time Outstanding of each series to be affected. The Indenture
also contains provisions permitting the Holders of specified percentages in principal amount of the Securities at the time Outstanding
of any series, on behalf of the Holders of all Securities of such series, to waive compliance by the Company with certain provisions of
the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Security
shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the registration
of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No reference herein to the Indenture or Supplemental
Indenture and no provision of this Security or of the Indenture or Supplemental Indenture shall alter or impair the obligation of the
Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security at the times, place
and rate, and in the coin or currency, herein prescribed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As provided in the Indenture and subject to certain
limitations therein set forth, the transfer of this Security is registerable in the Security Register, upon surrender of this Security
for registration of transfer at the office or agency of the Company in any place where the principal of and any premium and interest on
this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company and
the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Securities
of this series and of like tenor, of authorized denominations and for the same aggregate principal amount, will be issued to the designated
transferee or transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Securities of this series are issuable only
in registered form without coupons in denominations of $2,000 and any integral multiple of $1,000 in excess thereof. As provided in the
Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal
amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the Holder surrendering
the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No service charge shall be made for any registration
of transfer or exchange of the Notes, but the Company or the Security Registrar may require payment of a sum sufficient to cover any transfer
tax, assessments, or similar governmental charge payable in connection therewith (other than any such transfer taxes, assessments or similar
governmental charge payable upon exchange or transfer pursuant to Sections 9.6 or 11.7 of the Indenture).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Prior to due presentment of this Security for registration
of transfer, the Company, the Trustee and any agent of the Company or the Trustee will treat the Person in whose name this Security is
registered as the owner hereof for the purpose of receiving payments and for all other purposes, whether or not this Security be overdue,
and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All terms used in this Security which are defined
in the Indenture and Supplemental Indenture shall have the meanings assigned to them in the Indenture and Supplemental Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">THIS SECURITY SHALL BE GOVERNED BY AND CONSTRUED
IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Security is a Book-Entry Security within the
meaning of the Indenture hereinafter referred to and is registered in the name of a Depository or a nominee of a Depository. This Security
is exchangeable for Securities registered in the name of a person other than the Depository or its nominee only in the limited circumstances
described in the Indenture and may not be transferred except as a whole by the Depository to a nominee of the Depository or by a nominee
of the Depository to the Depository or another nominee of the Depository.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE TO BE DELIVERED UPON EXCHANGE<BR>
OR REGISTRATION OF TRANSFER OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Certificate relates to $<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;</U>
principal amount of Securities held in (check applicable space) <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> book-entry or <U>&nbsp;&nbsp;&nbsp;&nbsp;</U>
definitive form by <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
(the &ldquo;<U>Transferor</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Transferor (check one box below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD><TD>has requested the Trustee by written order to deliver in exchange for its beneficial interest in the global Security held by the Depository
a Security or Securities in definitive, registered form of authorized denominations in an aggregate principal amount equal to its beneficial
interest in such global Security (or the portion thereof indicated above); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD><TD>has requested the Trustee by written order to exchange or register the transfer of a Security or Securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[INSERT NAME OF TRANSFEROR]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 42%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE OF EXCHANGES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following exchanges, redemptions or purchases
of a part of this Book-Entry Security have been made:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 20%; padding-right: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: Black 0.5pt solid"><B>Date&nbsp;of<BR>
    Exchange/<BR>
    Redemption/<BR>
    Repurchase</B></P></TD>
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&nbsp;of<BR>
    decrease&nbsp;in<BR>
    Principal&nbsp;Amount<BR>
    of&nbsp;this&nbsp;Book-Entry<BR>
    Security</B></P></TD>
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&nbsp;of<BR>
    increase&nbsp;in<BR>
    Principal&nbsp;Amount<BR>
    of&nbsp;this&nbsp;Book-<BR>
    Entry&nbsp;Security</B></P></TD>
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Principal&nbsp;Amount<BR>
    of&nbsp;this&nbsp;Book-Entry<BR>
    Security&nbsp;following<BR>
    such&nbsp;decrease&nbsp;(or<BR>
    increase)</B></P></TD>
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Signature&nbsp;of<BR>
    authorized<BR>
    signatory&nbsp;of<BR>
    Trustee</B></P></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-right: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To assign this Security, fill in the form below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I or we assign and transfer this Security to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print or type assignee&rsquo;s name, address and zip code)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Insert assignee&rsquo;s soc. sec. or tax I.D. No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and irrevocably appoint <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
as agent to transfer this Security on the books of the Company. The agent may substitute another to act for him.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 6%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="width: 44%; border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your Signature*:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sign exactly as your name appears on the other
side of this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Signature Guaranteed:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">*NOTICE: The signature to this assignment must correspond with the
name as it appears upon the face of the within Note in every particular, without alteration, enlargement or any change whatever. Such
signature must be guaranteed by an &ldquo;eligible guarantor institution&rdquo; meeting the requirements of the Security Registrar, which
requirements include membership or participation in Security Transfer Agents Medallion Program (&ldquo;STAMP&rdquo;) or such other &ldquo;signature
guarantee program&rdquo; as may be determined by the Security Registrar in addition to, or in substitution for, STAMP, all in accordance
with the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;A2 &mdash; Form&nbsp;of 4.875%
Senior Notes due 2030</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ABBVIE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>4.875% Senior Notes due 2030</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%; font: bold 10pt Times New Roman, Times, Serif; text-align: left">No.&nbsp;[&bull;]</TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; width: 49%; font: bold 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$[&bull;]</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CUSIP No: 00287Y DZ9</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ISIN No: US00287YDZ97</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Security is a Security in a global form within
the meaning of the Indenture hereinafter referred to and is registered in the name of the Depository or a nominee of the Depository. This
global Security is exchangeable for Securities registered in the name of a Person other than the Depository or its nominee only in the
limited circumstances described in the Indenture, and no transfer of this Security (other than a transfer of this Security as a whole
by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or another nominee of the Depository)
may be registered except in such limited circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless this Security is presented by an authorized
representative of The Depository Trust Company to the issuer or its agent for registration of transfer, exchange or payment, and any Security
issued upon registration of transfer of, or in exchange for, or in lieu of, this Security is registered in the name of Cede&nbsp;&amp;
Co. or such other name as requested by an authorized representative of The Depository Trust Company and any payment hereon is made to
Cede&nbsp;&amp; Co., ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL since&nbsp;the registered
owner hereof, Cede&nbsp;&amp; Co., has an interest herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ABBVIE INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ABBVIE
INC., a corporation duly organized and existing under the laws of Delaware (herein called the &ldquo;<U>Company</U>,&rdquo; which term
includes any successor Person under the Indenture and Supplemental Indenture hereinafter referred to), for value received, hereby promises
to pay to Cede&nbsp;&amp; Co., as nominee for The Depository Trust Company, or registered assigns, the principal sum of [<B>&bull;</B></FONT>]
Dollars ($[<FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&bull;</B></FONT>]), or such other principal sum as may be indicated
on the Schedule of Exchanges attached hereto, on March&nbsp;15, 2030 and to pay interest thereon from February&nbsp;26, 2025 or from the
most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually in arrears on March&nbsp;15 and
September&nbsp;15 in each year, commencing September&nbsp;15, 2025, at the rate of 4.875% per annum, until the principal hereof is paid
or made available for payment. The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as
provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at
the close of business on the Regular Record Date for such interest, which shall be the date that is fifteen calendar days prior to the
relevant Interest Payment Date (whether or not a Business Day). Any such interest not so punctually paid or duly provided for will forthwith
cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Security (or one
or more Predecessor Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest
to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such
Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange
on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided
in said Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Payment of the principal of (and premium, if any)
and any such interest on this Security will be made at the office or agency of the Company maintained for that purpose in St. Paul, Minnesota,
in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts;
provided, however, that at the option of the Company payment of interest may be made by (1)&nbsp;check mailed to the address of the Person
entitled thereto as such address shall appear in the Security Register or (2)&nbsp;wire transfer as directed by the Holder, in immediately
available funds to an account maintained by the Depository or its nominee with respect to a Global Note, and to the Holder or its nominee
with respect to a Definitive Note; provided further that in the case of a Definitive Note (1)&nbsp;the Holder thereof shall have provided
written wiring instructions to the Trustee on or before the related Regular Record Date and (2)&nbsp;if appropriate instructions for any
such wire transfer are not received by the related Regular Record Date, then such payment shall be made by check mailed to the address
of the Holder specified in the Security Register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Reference is hereby made to the further provisions
of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same effect as if set forth
at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless the certificate of authentication hereon
has been executed by the Trustee referred to herein by manual signature, this Security shall not be entitled to any benefit under the
Indenture or be valid or obligatory for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the Company has caused this
instrument to be duly executed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: February&nbsp;26, 2025</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABBVIE
    INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 42%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott
    T. Reents</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer and Executive Vice President</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TRUSTEE&rsquo;S CERTIFICATE OF AUTHENTICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This is one of the Securities of the series designated
therein referred to in the within-mentioned Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: February&nbsp;26, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">U.S. BANK TRUST COMPANY, NATIONAL
    ASSOCIATION, <BR>
as Trustee</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 42%"><FONT STYLE="font-size: 10pt">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">[Authorized Officer]</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[FORM&nbsp;OF REVERSE OF SECURITY]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Security is one of a duly authorized issue
of securities of the Company (herein called the &ldquo;<U>Securities</U>&rdquo;), issued and to be issued in one or more series under
an Indenture, dated as of November&nbsp;8, 2012, as it may be supplemented or amended from time to time (herein called the &ldquo;<U>Indenture</U>&rdquo;),
between the Company and U.S. Bank Trust Company, National Association, as successor-in-interest to U.S. Bank National Association, as
trustee (herein called the &ldquo;<U>Trustee</U>,&rdquo; which term includes any successor trustee under the Indenture), and Supplemental
Indenture No.&nbsp;11, dated as of February&nbsp;26, 2025 (herein called the &ldquo;<U>Supplemental Indenture</U>&rdquo;), among the Company
and the Trustee, to which Indenture, Supplemental Indenture and all indentures supplemental thereto reference is hereby made for a statement
of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Securities
of this series and of the terms upon which the Securities of this series are, and are to be, authenticated and delivered. This Security
is one of the series designated on the face hereof, in an initial aggregate principal amount of $1,000,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At any time prior to the Par Call Date (as defined
below), the Company may redeem the Securities of this series at its option, in whole or in part, at any time and from time to time, at
a Redemption Price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(1)&nbsp;(a)&nbsp;the sum of the present values
of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming such Securities matured
on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 10
basis points, less (b)&nbsp;interest accrued to the date of redemption, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(2)&nbsp;100% of the principal amount of the Securities
of this series to be redeemed,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">plus, in either case, accrued and unpaid interest
thereon to the Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On or after the Par Call Date, the Company may
redeem the Securities of this series, in whole or in part, at any time and from time to time, at a Redemption Price equal to 100% of the
principal amount of the Securities of this series being redeemed plus accrued and unpaid interest thereon to the Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<U>Par
Call Date</U>&rdquo; means February&nbsp;15</FONT>, 2030 (the date that is one (1)&nbsp;month prior to the maturity date of the Securities
of this series).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Treasury Rate</U>&rdquo; means, with
respect to any Redemption Date for Securities of this series, the yield applicable to this series of Securities determined by the Company
in accordance with the following two paragraphs. The Treasury Rate applicable to this series of Securities shall be determined by the
Company after 4:15&nbsp;p.m., New York City time (or after such time as yields on U.S. government securities are posted daily by the Board
of Governors of the Federal Reserve System), on the third New York Business Day preceding such Redemption Date based upon the yield or
yields for the most recent day that appear after such time on such day in the most recent statistical release published by the Board of
Governors of the Federal Reserve System designated as &ldquo;Selected Interest Rates (Daily) &mdash; H.15&rdquo; (or any successor designation
or publication) (&ldquo;H.15&rdquo;) under the caption &ldquo;U.S. government securities &mdash; Treasury constant maturities &mdash;
Nominal&rdquo; (or any successor caption or heading) (&ldquo;H.15 TCM&rdquo;). In determining the applicable Treasury Rate, the Company
shall select, as applicable: (1)&nbsp;the yield for the Treasury constant maturity on H.15 exactly equal to the period from such Redemption
Date to the applicable Par Call Date (the &ldquo;Remaining Life&rdquo;); or (2)&nbsp;if there is no such Treasury constant maturity on
H.15 exactly equal to the Remaining Life, the two yields &mdash; one yield corresponding to the Treasury constant maturity on H.15 immediately
shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life &mdash;
and shall interpolate to the applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields and
rounding the result to three decimal places; or (3)&nbsp;if there is no such Treasury constant maturity on H.15 shorter than or longer
than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this
paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant
number of months or years, as applicable, of such Treasury constant maturity from such redemption date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If on the third New York Business Day preceding
such Redemption Date, H.15 TCM is no longer published, the Company shall calculate the applicable Treasury Rate based on the rate per
annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second New York Business Day preceding
such Redemption Date of the United States Treasury security maturing on, or with a maturity that is closest to, the Par Call Date, as
applicable. If there is no United States Treasury security maturing on the Par Call Date but there are two or more United States Treasury
securities with a maturity date equally distant from the applicable Par Call Date, one with a maturity date preceding the Par Call Date
and one with a maturity date following the Par Call Date, the Company shall select the United States Treasury security with a maturity
date preceding the Par Call Date. If there are two or more United States Treasury securities maturing on the Par Call Date or two or more
United States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among these two or more
United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid
and asked prices for such United States Treasury securities at 11:00 a.m., New York City time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In determining the applicable Treasury Rate in
accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall
be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time,
of such United States Treasury security, and rounded to three decimal places.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company&rsquo;s actions and determinations
in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No Securities of this series of a principal amount
of $2,000 or less will be redeemed in part. For so long as the Securities are held by The Depository Trust Company (or another depositary),
the redemption of the Securities shall be done in accordance with the policies and procedures of the applicable depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>New York Business Day</U>&rdquo; means
any calendar day that is not a Saturday, Sunday or legal holiday in New York, New York and on which commercial banks are open for business
in New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Securities of this series do not provide for
a sinking fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If an Event of Default with respect to Securities
of this series shall occur and be continuing, the principal of the Securities of this series may be declared due and payable in the manner
and with the effect provided in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Indenture contains provisions for defeasance
at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect to this Security,
in each case upon compliance with certain conditions set forth therein. Sections 13.2 and 13.3 of the Indenture apply to the Securities
of this series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Indenture permits, with certain exceptions
as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders
of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with the consent of the
Holders of not less than a majority in principal amount of the Securities at the time Outstanding of each series to be affected. The Indenture
also contains provisions permitting the Holders of specified percentages in principal amount of the Securities at the time Outstanding
of any series, on behalf of the Holders of all Securities of such series, to waive compliance by the Company with certain provisions of
the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Security
shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the registration
of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No reference herein to the Indenture or Supplemental
Indenture and no provision of this Security or of the Indenture or Supplemental Indenture shall alter or impair the obligation of the
Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security at the times, place
and rate, and in the coin or currency, herein prescribed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As provided in the Indenture and subject to certain
limitations therein set forth, the transfer of this Security is registerable in the Security Register, upon surrender of this Security
for registration of transfer at the office or agency of the Company in any place where the principal of and any premium and interest on
this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company and
the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Securities
of this series and of like tenor, of authorized denominations and for the same aggregate principal amount, will be issued to the designated
transferee or transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Securities of this series are issuable only
in registered form without coupons in denominations of $2,000 and any integral multiple of $1,000 in excess thereof. As provided in the
Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal
amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the Holder surrendering
the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No service charge shall be made for any registration
of transfer or exchange of the Notes, but the Company or the Security Registrar may require payment of a sum sufficient to cover any transfer
tax, assessments, or similar governmental charge payable in connection therewith (other than any such transfer taxes, assessments or similar
governmental charge payable upon exchange or transfer pursuant to Sections 9.6 or 11.7 of the Indenture).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Prior to due presentment of this Security for registration
of transfer, the Company, the Trustee and any agent of the Company or the Trustee will treat the Person in whose name this Security is
registered as the owner hereof for the purpose of receiving payments and for all other purposes, whether or not this Security be overdue,
and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All terms used in this Security which are defined
in the Indenture and Supplemental Indenture shall have the meanings assigned to them in the Indenture and Supplemental Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">THIS SECURITY SHALL BE GOVERNED BY AND CONSTRUED
IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Security is a Book-Entry Security within the
meaning of the Indenture hereinafter referred to and is registered in the name of a Depository or a nominee of a Depository. This Security
is exchangeable for Securities registered in the name of a person other than the Depository or its nominee only in the limited circumstances
described in the Indenture and may not be transferred except as a whole by the Depository to a nominee of the Depository or by a nominee
of the Depository to the Depository or another nominee of the Depository.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE TO BE DELIVERED UPON EXCHANGE<BR>
OR REGISTRATION OF TRANSFER OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Certificate relates to $<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;</U>
principal amount of Securities held in (check applicable space) <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> book-entry or <U>&nbsp;&nbsp;&nbsp;&nbsp;</U>
definitive form by <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
(the &ldquo;<U>Transferor</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Transferor (check one box below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD><TD>has requested the Trustee by written order to deliver in exchange for its beneficial interest in the global Security held by the Depository
a Security or Securities in definitive, registered form of authorized denominations in an aggregate principal amount equal to its beneficial
interest in such global Security (or the portion thereof indicated above); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD><TD>has requested the Trustee by written order to exchange or register the transfer of a Security or Securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[INSERT
    NAME OF TRANSFEROR]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 41%"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE OF EXCHANGES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following exchanges, redemptions or purchases
of a part of this Book-Entry Security have been made:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 20%; padding-right: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: Black 0.5pt solid"><B>Date&nbsp;of<BR>
    Exchange/<BR>
    Redemption/<BR>
    Repurchase</B></P></TD>
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&nbsp;of<BR>
    decrease&nbsp;in<BR>
    Principal&nbsp;Amount<BR>
    of&nbsp;this&nbsp;Book-Entry<BR>
    Security</B></P></TD>
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&nbsp;of<BR>
    increase&nbsp;in<BR>
    Principal&nbsp;Amount<BR>
    of&nbsp;this&nbsp;Book-<BR>
    Entry&nbsp;Security</B></P></TD>
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Principal&nbsp;Amount<BR>
    of&nbsp;this&nbsp;Book-Entry<BR>
    Security&nbsp;following<BR>
    such&nbsp;decrease&nbsp;(or<BR>
    increase)</B></P></TD>
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Signature&nbsp;of<BR>
    authorized<BR>
    signatory&nbsp;of<BR>
    Trustee</B></P></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-right: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To assign this Security, fill in the form below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I or we assign and transfer this Security to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print or type assignee&rsquo;s name, address and zip code)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Insert assignee&rsquo;s soc. sec. or tax I.D. No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and irrevocably appoint <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
as agent to transfer this Security on the books of the Company. The agent may substitute another to act for him.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 6%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="width: 44%; border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your Signature*:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sign exactly as your name appears on the other
side of this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 15%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Signature Guaranteed:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">*NOTICE: The signature to this assignment must correspond with the
name as it appears upon the face of the within Note in every particular, without alteration, enlargement or any change whatever. Such
signature must be guaranteed by an &ldquo;eligible guarantor institution&rdquo; meeting the requirements of the Security Registrar, which
requirements include membership or participation in Security Transfer Agents Medallion Program (&ldquo;STAMP&rdquo;) or such other &ldquo;signature
guarantee program&rdquo; as may be determined by the Security Registrar in addition to, or in substitution for, STAMP, all in accordance
with the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;A3 &mdash; Form&nbsp;of 5.200%
Senior Notes due 2035</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ABBVIE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>5.200% Senior Notes due 2035</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%; font: bold 10pt Times New Roman, Times, Serif; text-align: left">No.&nbsp;[&bull;]</TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; width: 49%; font: bold 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$[&bull;]</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CUSIP No: 00287Y EA3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ISIN No:US00287YEA38</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Security is a Security in a global form within
the meaning of the Indenture hereinafter referred to and is registered in the name of the Depository or a nominee of the Depository. This
global Security is exchangeable for Securities registered in the name of a Person other than the Depository or its nominee only in the
limited circumstances described in the Indenture, and no transfer of this Security (other than a transfer of this Security as a whole
by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or another nominee of the Depository)
may be registered except in such limited circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless this Security is presented by an authorized
representative of The Depository Trust Company to the issuer or its agent for registration of transfer, exchange or payment, and any Security
issued upon registration of transfer of, or in exchange for, or in lieu of, this Security is registered in the name of Cede&nbsp;&amp;
Co. or such other name as requested by an authorized representative of The Depository Trust Company and any payment hereon is made to
Cede&nbsp;&amp; Co., ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL since&nbsp;the registered
owner hereof, Cede&nbsp;&amp; Co., has an interest herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ABBVIE INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ABBVIE
INC., a corporation duly organized and existing under the laws of Delaware (herein called the &ldquo;<U>Company</U>,&rdquo; which term
includes any successor Person under the Indenture and Supplemental Indenture hereinafter referred to), for value received, hereby promises
to pay to Cede&nbsp;&amp; Co., as nominee for The Depository Trust Company, or registered assigns, the principal sum of [<B>&bull;</B></FONT>]
Dollars ($[<FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&bull;</B></FONT>]), or such other principal sum as may be indicated
on the Schedule of Exchanges attached hereto, on March&nbsp;15, 2035 and to pay interest thereon from February&nbsp;26, 2025 or from the
most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually in arrears on March&nbsp;15 and
September&nbsp;15 in each year, commencing September&nbsp;15, 2025, at the rate of 5.200% per annum, until the principal hereof is paid
or made available for payment. The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as
provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at
the close of business on the Regular Record Date for such interest, which shall be the date that is fifteen calendar days prior to the
relevant Interest Payment Date (whether or not a Business Day). Any such interest not so punctually paid or duly provided for will forthwith
cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Security (or one
or more Predecessor Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest
to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such
Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange
on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided
in said Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Payment of the principal of (and premium, if any)
and any such interest on this Security will be made at the office or agency of the Company maintained for that purpose in St. Paul, Minnesota,
in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts;
provided, however, that at the option of the Company payment of interest may be made by (1)&nbsp;check mailed to the address of the Person
entitled thereto as such address shall appear in the Security Register or (2)&nbsp;wire transfer as directed by the Holder, in immediately
available funds to an account maintained by the Depository or its nominee with respect to a Global Note, and to the Holder or its nominee
with respect to a Definitive Note; provided further that in the case of a Definitive Note (1)&nbsp;the Holder thereof shall have provided
written wiring instructions to the Trustee on or before the related Regular Record Date and (2)&nbsp;if appropriate instructions for any
such wire transfer are not received by the related Regular Record Date, then such payment shall be made by check mailed to the address
of the Holder specified in the Security Register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Reference is hereby made to the further provisions
of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same effect as if set forth
at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless the certificate of authentication hereon
has been executed by the Trustee referred to herein by manual signature, this Security shall not be entitled to any benefit under the
Indenture or be valid or obligatory for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the Company has caused this
instrument to be duly executed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: February&nbsp;26, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">ABBVIE INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 42%"><FONT STYLE="font-size: 10pt">Scott T. Reents</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Chief Financial Officer and Executive Vice President</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TRUSTEE&rsquo;S CERTIFICATE OF AUTHENTICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This is one of the Securities of the series designated
therein referred to in the within-mentioned Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: February&nbsp;26, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">U.S.
    BANK TRUST COMPANY, NATIONAL ASSOCIATION, <BR>
    as Trustee</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 42%"><FONT STYLE="font-size: 10pt">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">[Authorized Officer]</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[FORM&nbsp;OF REVERSE OF SECURITY]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Security is one of a duly authorized issue
of securities of the Company (herein called the &ldquo;<U>Securities</U>&rdquo;), issued and to be issued in one or more series under
an Indenture, dated as of November&nbsp;8, 2012, as it may be supplemented or amended from time to time (herein called the &ldquo;<U>Indenture</U>&rdquo;),
between the Company and U.S. Bank Trust Company, National Association, as successor-in-interest to U.S. Bank National Association, as
trustee (herein called the &ldquo;<U>Trustee</U>,&rdquo; which term includes any successor trustee under the Indenture), and Supplemental
Indenture No.&nbsp;11, dated as of February&nbsp;26, 2025 (herein called the &ldquo;<U>Supplemental Indenture</U>&rdquo;), among the Company
and the Trustee, to which Indenture, Supplemental Indenture and all indentures supplemental thereto reference is hereby made for a statement
of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Securities
of this series and of the terms upon which the Securities of this series are, and are to be, authenticated and delivered. This Security
is one of the series designated on the face hereof, in an initial aggregate principal amount of $1,000,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At any time prior to the Par Call Date (as defined
below), the Company may redeem the Securities of this series at its option, in whole or in part, at any time and from time to time, at
a Redemption Price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(1)&nbsp;(a)&nbsp;the sum of the present values
of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming such Securities matured
on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 15
basis points, less (b)&nbsp;interest accrued to the date of redemption, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(2)&nbsp;100% of the principal amount of the Securities
of this series to be redeemed,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">plus, in either case, accrued and unpaid interest
thereon to the Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On or after the Par Call Date, the Company may
redeem the Securities of this series, in whole or in part, at any time and from time to time, at a Redemption Price equal to 100% of the
principal amount of the Securities of this series being redeemed plus accrued and unpaid interest thereon to the Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<U>Par
Call Date</U>&rdquo; means December&nbsp;15</FONT>, 2034 (the date that is three (3)&nbsp;months prior to the maturity date of the Securities
of this series).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Treasury Rate</U>&rdquo; means, with
respect to any Redemption Date for Securities of this series, the yield applicable to this series of Securities determined by the Company
in accordance with the following two paragraphs. The Treasury Rate applicable to this series of Securities shall be determined by the
Company after 4:15&nbsp;p.m., New York City time (or after such time as yields on U.S. government securities are posted daily by the Board
of Governors of the Federal Reserve System), on the third New York Business Day preceding such Redemption Date based upon the yield or
yields for the most recent day that appear after such time on such day in the most recent statistical release published by the Board of
Governors of the Federal Reserve System designated as &ldquo;Selected Interest Rates (Daily) &mdash; H.15&rdquo; (or any successor designation
or publication) (&ldquo;H.15&rdquo;) under the caption &ldquo;U.S. government securities &mdash; Treasury constant maturities &mdash;
Nominal&rdquo; (or any successor caption or heading) (&ldquo;H.15 TCM&rdquo;). In determining the applicable Treasury Rate, the Company
shall select, as applicable: (1)&nbsp;the yield for the Treasury constant maturity on H.15 exactly equal to the period from such Redemption
Date to the applicable Par Call Date (the &ldquo;Remaining Life&rdquo;); or (2)&nbsp;if there is no such Treasury constant maturity on
H.15 exactly equal to the Remaining Life, the two yields &mdash; one yield corresponding to the Treasury constant maturity on H.15 immediately
shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life &mdash;
and shall interpolate to the applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields and
rounding the result to three decimal places; or (3)&nbsp;if there is no such Treasury constant maturity on H.15 shorter than or longer
than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this
paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant
number of months or years, as applicable, of such Treasury constant maturity from such redemption date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If on the third New York Business Day preceding
such Redemption Date, H.15 TCM is no longer published, the Company shall calculate the applicable Treasury Rate based on the rate per
annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second New York Business Day preceding
such Redemption Date of the United States Treasury security maturing on, or with a maturity that is closest to, the Par Call Date, as
applicable. If there is no United States Treasury security maturing on the Par Call Date but there are two or more United States Treasury
securities with a maturity date equally distant from the applicable Par Call Date, one with a maturity date preceding the Par Call Date
and one with a maturity date following the Par Call Date, the Company shall select the United States Treasury security with a maturity
date preceding the Par Call Date. If there are two or more United States Treasury securities maturing on the Par Call Date or two or more
United States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among these two or more
United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid
and asked prices for such United States Treasury securities at 11:00 a.m., New York City time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In determining the applicable Treasury Rate in
accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall
be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time,
of such United States Treasury security, and rounded to three decimal places.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company&rsquo;s actions and determinations
in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No Securities of this series of a principal amount
of $2,000 or less will be redeemed in part. For so long as the Securities are held by The Depository Trust Company (or another depositary),
the redemption of the Securities shall be done in accordance with the policies and procedures of the applicable depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>New York Business Day</U>&rdquo; means
any calendar day that is not a Saturday, Sunday or legal holiday in New York, New York and on which commercial banks are open for business
in New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Securities of this series do not provide for
a sinking fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If an Event of Default with respect to Securities
of this series shall occur and be continuing, the principal of the Securities of this series may be declared due and payable in the manner
and with the effect provided in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Indenture contains provisions for defeasance
at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect to this Security,
in each case upon compliance with certain conditions set forth therein. Sections 13.2 and 13.3 of the Indenture apply to the Securities
of this series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Indenture permits, with certain exceptions
as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders
of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with the consent of the
Holders of not less than a majority in principal amount of the Securities at the time Outstanding of each series to be affected. The Indenture
also contains provisions permitting the Holders of specified percentages in principal amount of the Securities at the time Outstanding
of any series, on behalf of the Holders of all Securities of such series, to waive compliance by the Company with certain provisions of
the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Security
shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the registration
of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No reference herein to the Indenture or Supplemental
Indenture and no provision of this Security or of the Indenture or Supplemental Indenture shall alter or impair the obligation of the
Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security at the times, place
and rate, and in the coin or currency, herein prescribed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As provided in the Indenture and subject to certain
limitations therein set forth, the transfer of this Security is registerable in the Security Register, upon surrender of this Security
for registration of transfer at the office or agency of the Company in any place where the principal of and any premium and interest on
this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company and
the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Securities
of this series and of like tenor, of authorized denominations and for the same aggregate principal amount, will be issued to the designated
transferee or transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Securities of this series are issuable only
in registered form without coupons in denominations of $2,000 and any integral multiple of $1,000 in excess thereof. As provided in the
Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal
amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the Holder surrendering
the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No service charge shall be made for any registration
of transfer or exchange of the Notes, but the Company or the Security Registrar may require payment of a sum sufficient to cover any transfer
tax, assessments, or similar governmental charge payable in connection therewith (other than any such transfer taxes, assessments or similar
governmental charge payable upon exchange or transfer pursuant to Sections 9.6 or 11.7 of the Indenture).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Prior to due presentment of this Security for registration
of transfer, the Company, the Trustee and any agent of the Company or the Trustee will treat the Person in whose name this Security is
registered as the owner hereof for the purpose of receiving payments and for all other purposes, whether or not this Security be overdue,
and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All terms used in this Security which are defined
in the Indenture and Supplemental Indenture shall have the meanings assigned to them in the Indenture and Supplemental Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">THIS SECURITY SHALL BE GOVERNED BY AND CONSTRUED
IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Security is a Book-Entry Security within the
meaning of the Indenture hereinafter referred to and is registered in the name of a Depository or a nominee of a Depository. This Security
is exchangeable for Securities registered in the name of a person other than the Depository or its nominee only in the limited circumstances
described in the Indenture and may not be transferred except as a whole by the Depository to a nominee of the Depository or by a nominee
of the Depository to the Depository or another nominee of the Depository.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE TO BE DELIVERED UPON EXCHANGE<BR>
OR REGISTRATION OF TRANSFER OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Certificate relates to $<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;</U>
principal amount of Securities held in (check applicable space) <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> book-entry or <U>&nbsp;&nbsp;&nbsp;&nbsp;</U>
definitive form by <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
(the &ldquo;<U>Transferor</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Transferor (check one box below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD><TD>has requested the Trustee by written order to deliver in exchange for its beneficial interest in the global Security held by the Depository
a Security or Securities in definitive, registered form of authorized denominations in an aggregate principal amount equal to its beneficial
interest in such global Security (or the portion thereof indicated above); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD><TD>has requested the Trustee by written order to exchange or register the transfer of a Security or Securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[INSERT
    NAME OF TRANSFEROR]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 41%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE OF EXCHANGES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following exchanges, redemptions or purchases
of a part of this Book-Entry Security have been made:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 20%; padding-right: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: Black 0.5pt solid"><B>Date&nbsp;of<BR>
    Exchange/<BR>
    Redemption/<BR>
    Repurchase</B></P></TD>
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&nbsp;of<BR>
    decrease&nbsp;in<BR>
    Principal&nbsp;Amount<BR>
    of&nbsp;this&nbsp;Book-Entry<BR>
    Security</B></P></TD>
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&nbsp;of<BR>
    increase&nbsp;in<BR>
    Principal&nbsp;Amount<BR>
    of&nbsp;this&nbsp;Book-<BR>
    Entry&nbsp;Security</B></P></TD>
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Principal&nbsp;Amount<BR>
    of&nbsp;this&nbsp;Book-Entry<BR>
    Security&nbsp;following<BR>
    such&nbsp;decrease&nbsp;(or<BR>
    increase)</B></P></TD>
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Signature&nbsp;of<BR>
    authorized<BR>
    signatory&nbsp;of<BR>
    Trustee</B></P></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-right: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To assign this Security, fill in the form below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I or we assign and transfer this Security to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print or type assignee&rsquo;s name, address and zip code)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Insert assignee&rsquo;s soc. sec. or tax I.D. No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and irrevocably appoint <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
as agent to transfer this Security on the books of the Company. The agent may substitute another to act for him.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 6%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="width: 44%; border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your Signature*:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sign exactly as your name appears on the other
side of this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 15%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Signature Guaranteed:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">*NOTICE: The signature to this assignment must correspond with the
name as it appears upon the face of the within Note in every particular, without alteration, enlargement or any change whatever. Such
signature must be guaranteed by an &ldquo;eligible guarantor institution&rdquo; meeting the requirements of the Security Registrar, which
requirements include membership or participation in Security Transfer Agents Medallion Program (&ldquo;STAMP&rdquo;) or such other &ldquo;signature
guarantee program&rdquo; as may be determined by the Security Registrar in addition to, or in substitution for, STAMP, all in accordance
with the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;A4 &mdash; Form&nbsp;of 5.600%
Senior Notes due 2055</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ABBVIE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>5.600% Senior Notes due 2055</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%; font: bold 10pt Times New Roman, Times, Serif; text-align: left">No.&nbsp;[&bull;]</TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; width: 49%; font: bold 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$[&bull;]</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CUSIP No: 00287Y EB1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ISIN No: US00287YEB11</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Security is a Security in a global form within
the meaning of the Indenture hereinafter referred to and is registered in the name of the Depository or a nominee of the Depository. This
global Security is exchangeable for Securities registered in the name of a Person other than the Depository or its nominee only in the
limited circumstances described in the Indenture, and no transfer of this Security (other than a transfer of this Security as a whole
by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or another nominee of the Depository)
may be registered except in such limited circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless this Security is presented by an authorized
representative of The Depository Trust Company to the issuer or its agent for registration of transfer, exchange or payment, and any Security
issued upon registration of transfer of, or in exchange for, or in lieu of, this Security is registered in the name of Cede&nbsp;&amp;
Co. or such other name as requested by an authorized representative of The Depository Trust Company and any payment hereon is made to
Cede&nbsp;&amp; Co., ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL since&nbsp;the registered
owner hereof, Cede&nbsp;&amp; Co., has an interest herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ABBVIE INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ABBVIE
INC., a corporation duly organized and existing under the laws of Delaware (herein called the &ldquo;<U>Company</U>,&rdquo; which term
includes any successor Person under the Indenture and Supplemental Indenture hereinafter referred to), for value received, hereby promises
to pay to Cede&nbsp;&amp; Co., as nominee for The Depository Trust Company, or registered assigns, the principal sum of [<B>&bull;</B></FONT>]
Dollars ($[<FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&bull;</B></FONT>]), or such other principal sum as may be indicated
on the Schedule of Exchanges attached hereto, on March&nbsp;15, 2055 and to pay interest thereon from February&nbsp;26, 2025 or from the
most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually in arrears on March&nbsp;15 and
September&nbsp;15 in each year, commencing September&nbsp;15, 2025, at the rate of 5.600% per annum, until the principal hereof is paid
or made available for payment. The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as
provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at
the close of business on the Regular Record Date for such interest, which shall be the date that is fifteen calendar days prior to the
relevant Interest Payment Date (whether or not a Business Day). Any such interest not so punctually paid or duly provided for will forthwith
cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Security (or one
or more Predecessor Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest
to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such
Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange
on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided
in said Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 46; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Payment of the principal of (and premium, if any)
and any such interest on this Security will be made at the office or agency of the Company maintained for that purpose in St. Paul, Minnesota,
in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts;
provided, however, that at the option of the Company payment of interest may be made by (1)&nbsp;check mailed to the address of the Person
entitled thereto as such address shall appear in the Security Register or (2)&nbsp;wire transfer as directed by the Holder, in immediately
available funds to an account maintained by the Depository or its nominee with respect to a Global Note, and to the Holder or its nominee
with respect to a Definitive Note; provided further that in the case of a Definitive Note (1)&nbsp;the Holder thereof shall have provided
written wiring instructions to the Trustee on or before the related Regular Record Date and (2)&nbsp;if appropriate instructions for any
such wire transfer are not received by the related Regular Record Date, then such payment shall be made by check mailed to the address
of the Holder specified in the Security Register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Reference is hereby made to the further provisions
of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same effect as if set forth
at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless the certificate of authentication hereon
has been executed by the Trustee referred to herein by manual signature, this Security shall not be entitled to any benefit under the
Indenture or be valid or obligatory for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the Company has caused this
instrument to be duly executed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: February&nbsp;26, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">ABBVIE INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 42%"><FONT STYLE="font-size: 10pt">Scott T. Reents</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Chief Financial Officer and Executive Vice President</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TRUSTEE&rsquo;S CERTIFICATE OF AUTHENTICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This is one of the Securities of the series designated
therein referred to in the within-mentioned Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: February&nbsp;26, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">U.S.
    BANK TRUST COMPANY, NATIONAL ASSOCIATION,<BR> as Trustee</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 42%"><FONT STYLE="font-size: 10pt">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">[Authorized Officer]</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[FORM&nbsp;OF REVERSE OF SECURITY]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Security is one of a duly authorized issue
of securities of the Company (herein called the &ldquo;<U>Securities</U>&rdquo;), issued and to be issued in one or more series under
an Indenture, dated as of November&nbsp;8, 2012, as it may be supplemented or amended from time to time (herein called the &ldquo;<U>Indenture</U>&rdquo;),
between the Company and U.S. Bank Trust Company, National Association, as successor-in-interest to U.S. Bank National Association, as
trustee (herein called the &ldquo;<U>Trustee</U>,&rdquo; which term includes any successor trustee under the Indenture), and Supplemental
Indenture No.&nbsp;11, dated as of February&nbsp;26, 2025 (herein called the &ldquo;<U>Supplemental Indenture</U>&rdquo;), among the Company
and the Trustee, to which Indenture, Supplemental Indenture and all indentures supplemental thereto reference is hereby made for a statement
of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Securities
of this series and of the terms upon which the Securities of this series are, and are to be, authenticated and delivered. This Security
is one of the series designated on the face hereof, in an initial aggregate principal amount of $750,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At any time prior to the Par Call Date (as defined
below), the Company may redeem the Securities of this series at its option, in whole or in part, at any time and from time to time, at
a Redemption Price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(1)&nbsp;(a)&nbsp;the sum of the present values
of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming such Securities matured
on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 15
basis points, less (b)&nbsp;interest accrued to the date of redemption, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(2)&nbsp;100% of the principal amount of the Securities
of this series to be redeemed,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">plus, in either case, accrued and unpaid interest
thereon to the Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On or after the Par Call Date, the Company may
redeem the Securities of this series, in whole or in part, at any time and from time to time, at a Redemption Price equal to 100% of the
principal amount of the Securities of this series being redeemed plus accrued and unpaid interest thereon to the Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<U>Par
Call Date</U>&rdquo; means September&nbsp;15</FONT>, 2054 (the date that is six (6)&nbsp;months prior to the maturity date of the Securities
of this series).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>Treasury Rate</U>&rdquo; means, with
respect to any Redemption Date for Securities of this series, the yield applicable to this series of Securities determined by the Company
in accordance with the following two paragraphs. The Treasury Rate applicable to this series of Securities shall be determined by the
Company after 4:15&nbsp;p.m., New York City time (or after such time as yields on U.S. government securities are posted daily by the Board
of Governors of the Federal Reserve System), on the third New York Business Day preceding such Redemption Date based upon the yield or
yields for the most recent day that appear after such time on such day in the most recent statistical release published by the Board of
Governors of the Federal Reserve System designated as &ldquo;Selected Interest Rates (Daily) &mdash; H.15&rdquo; (or any successor designation
or publication) (&ldquo;H.15&rdquo;) under the caption &ldquo;U.S. government securities &mdash; Treasury constant maturities &mdash;
Nominal&rdquo; (or any successor caption or heading) (&ldquo;H.15 TCM&rdquo;). In determining the applicable Treasury Rate, the Company
shall select, as applicable: (1)&nbsp;the yield for the Treasury constant maturity on H.15 exactly equal to the period from such Redemption
Date to the applicable Par Call Date (the &ldquo;Remaining Life&rdquo;); or (2)&nbsp;if there is no such Treasury constant maturity on
H.15 exactly equal to the Remaining Life, the two yields &mdash; one yield corresponding to the Treasury constant maturity on H.15 immediately
shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life &mdash;
and shall interpolate to the applicable Par Call Date on a straight-line basis (using the actual number of days) using such yields and
rounding the result to three decimal places; or (3)&nbsp;if there is no such Treasury constant maturity on H.15 shorter than or longer
than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this
paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant
number of months or years, as applicable, of such Treasury constant maturity from such redemption date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If on the third New York Business Day preceding
such Redemption Date, H.15 TCM is no longer published, the Company shall calculate the applicable Treasury Rate based on the rate per
annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second New York Business Day preceding
such Redemption Date of the United States Treasury security maturing on, or with a maturity that is closest to, the Par Call Date, as
applicable. If there is no United States Treasury security maturing on the Par Call Date but there are two or more United States Treasury
securities with a maturity date equally distant from the applicable Par Call Date, one with a maturity date preceding the Par Call Date
and one with a maturity date following the Par Call Date, the Company shall select the United States Treasury security with a maturity
date preceding the Par Call Date. If there are two or more United States Treasury securities maturing on the Par Call Date or two or more
United States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among these two or more
United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid
and asked prices for such United States Treasury securities at 11:00 a.m., New York City time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In determining the applicable Treasury Rate in
accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall
be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time,
of such United States Treasury security, and rounded to three decimal places.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company&rsquo;s actions and determinations
in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No Securities of this series of a principal amount
of $2,000 or less will be redeemed in part. For so long as the Securities are held by The Depository Trust Company (or another depositary),
the redemption of the Securities shall be done in accordance with the policies and procedures of the applicable depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>New York Business Day</U>&rdquo; means
any calendar day that is not a Saturday, Sunday or legal holiday in New York, New York and on which commercial banks are open for business
in New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Securities of this series do not provide for
a sinking fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If an Event of Default with respect to Securities
of this series shall occur and be continuing, the principal of the Securities of this series may be declared due and payable in the manner
and with the effect provided in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Indenture contains provisions for defeasance
at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect to this Security,
in each case upon compliance with certain conditions set forth therein. Sections 13.2 and 13.3 of the Indenture apply to the Securities
of this series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Indenture permits, with certain exceptions
as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders
of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with the consent of the
Holders of not less than a majority in principal amount of the Securities at the time Outstanding of each series to be affected. The Indenture
also contains provisions permitting the Holders of specified percentages in principal amount of the Securities at the time Outstanding
of any series, on behalf of the Holders of all Securities of such series, to waive compliance by the Company with certain provisions of
the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Security
shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the registration
of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No reference herein to the Indenture or Supplemental
Indenture and no provision of this Security or of the Indenture or Supplemental Indenture shall alter or impair the obligation of the
Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security at the times, place
and rate, and in the coin or currency, herein prescribed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As provided in the Indenture and subject to certain
limitations therein set forth, the transfer of this Security is registerable in the Security Register, upon surrender of this Security
for registration of transfer at the office or agency of the Company in any place where the principal of and any premium and interest on
this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company and
the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Securities
of this series and of like tenor, of authorized denominations and for the same aggregate principal amount, will be issued to the designated
transferee or transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Securities of this series are issuable only
in registered form without coupons in denominations of $2,000 and any integral multiple of $1,000 in excess thereof. As provided in the
Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal
amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the Holder surrendering
the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No service charge shall be made for any registration
of transfer or exchange of the Notes, but the Company or the Security Registrar may require payment of a sum sufficient to cover any transfer
tax, assessments, or similar governmental charge payable in connection therewith (other than any such transfer taxes, assessments or similar
governmental charge payable upon exchange or transfer pursuant to Sections 9.6 or 11.7 of the Indenture).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Prior to due presentment of this Security for registration
of transfer, the Company, the Trustee and any agent of the Company or the Trustee will treat the Person in whose name this Security is
registered as the owner hereof for the purpose of receiving payments and for all other purposes, whether or not this Security be overdue,
and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All terms used in this Security which are defined
in the Indenture and Supplemental Indenture shall have the meanings assigned to them in the Indenture and Supplemental Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">THIS SECURITY SHALL BE GOVERNED BY AND CONSTRUED
IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Security is a Book-Entry Security within the
meaning of the Indenture hereinafter referred to and is registered in the name of a Depository or a nominee of a Depository. This Security
is exchangeable for Securities registered in the name of a person other than the Depository or its nominee only in the limited circumstances
described in the Indenture and may not be transferred except as a whole by the Depository to a nominee of the Depository or by a nominee
of the Depository to the Depository or another nominee of the Depository.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE TO BE DELIVERED UPON EXCHANGE<BR>
OR REGISTRATION OF TRANSFER OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Certificate relates to $<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;</U>
principal amount of Securities held in (check applicable space) <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> book-entry or <U>&nbsp;&nbsp;&nbsp;&nbsp;</U>
definitive form by <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
(the &ldquo;<U>Transferor</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Transferor (check one box below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD><TD>has requested the Trustee by written order to deliver in exchange for its beneficial interest in the global Security held by the Depository
a Security or Securities in definitive, registered form of authorized denominations in an aggregate principal amount equal to its beneficial
interest in such global Security (or the portion thereof indicated above); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings"></FONT><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD>has requested the Trustee by written order to exchange or register the transfer of a Security or Securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[INSERT NAME OF TRANSFEROR]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 41%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE OF EXCHANGES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following exchanges, redemptions or purchases
of a part of this Book-Entry Security have been made:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 20%; padding-right: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: Black 0.5pt solid"><B>Date&nbsp;of<BR>
    Exchange/<BR>
    Redemption/<BR>
    Repurchase</B></P></TD>
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&nbsp;of<BR>
    decrease&nbsp;in<BR>
    Principal&nbsp;Amount<BR>
    of&nbsp;this&nbsp;Book-Entry<BR>
    Security</B></P></TD>
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&nbsp;of<BR>
    increase&nbsp;in<BR>
    Principal&nbsp;Amount<BR>
    of&nbsp;this&nbsp;Book-<BR>
    Entry&nbsp;Security</B></P></TD>
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Principal&nbsp;Amount<BR>
    of&nbsp;this&nbsp;Book-Entry<BR>
    Security&nbsp;following<BR>
    such&nbsp;decrease&nbsp;(or<BR>
    increase)</B></P></TD>
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Signature&nbsp;of<BR>
    authorized<BR>
    signatory&nbsp;of<BR>
    Trustee</B></P></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-right: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To assign this Security, fill in the form below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I or we assign and transfer this Security to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print or type assignee&rsquo;s name, address and zip code)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Insert assignee&rsquo;s soc. sec. or tax I.D. No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and irrevocably appoint <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
as agent to transfer this Security on the books of the Company. The agent may substitute another to act for him.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 6%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="width: 44%; border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your Signature*:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sign exactly as your name appears on the other
side of this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 15%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Signature Guaranteed:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">*NOTICE: The signature to this assignment must correspond with the
name as it appears upon the face of the within Note in every particular, without alteration, enlargement or any change whatever. Such
signature must be guaranteed by an &ldquo;eligible guarantor institution&rdquo; meeting the requirements of the Security Registrar, which
requirements include membership or participation in Security Transfer Agents Medallion Program (&ldquo;STAMP&rdquo;) or such other &ldquo;signature
guarantee program&rdquo; as may be determined by the Security Registrar in addition to, or in substitution for, STAMP, all in accordance
with the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 56; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>tm255723d7_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="tm255723d7_ex5-1img001.jpg" ALT=""></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD COLSPAN="6" STYLE="padding-top: 3pt; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="5" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">MARTIN
    LIPTON<BR>
    HERBERT M. WACHTELL<BR>
    EDWARD D. HERLIHY<BR>
    DANIEL A. NEFF<BR>
    STEVEN A. ROSENBLUM<BR>
    SCOTT K. CHARLES<BR>
    JODI J. SCHWARTZ<BR>
    ADAM O. EMMERICH<BR>
    RALPH M. LEVENE<BR>
    ROBIN PANOVKA<BR>
    DAVID A. KATZ<BR>
    ILENE KNABLE GOTTS<BR>
    ANDREW J. NUSSBAUM<BR>
    RACHELLE SILVERBERG<BR>
    STEVEN A. COHEN<BR>
    DEBORAH L. PAUL<BR>
    DAVID C. KARP<BR>
    RICHARD K. KIM<BR>
    JOSHUA R. CAMMAKER<BR>
    MARK GORDON<BR>
    JEANNEMARIE O&rsquo;BRIEN</FONT></TD>
    <TD ROWSPAN="5" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">STEPHEN
    R. DiPRIMA<BR>
    NICHOLAS G. DEMMO<BR>
    IGOR KIRMAN<BR>
    JONATHAN M. MOSES<BR>
    T. EIKO STANGE<BR>
    WILLIAM SAVITT<BR>
    GREGORY E. OSTLING<BR>
    DAVID B. ANDERS<BR>
    ADAM J. SHAPIRO<BR>
    NELSON O. FITTS<BR>
    JOSHUA M. HOLMES<BR>
    DAVID E. SHAPIRO<BR>
    DAMIAN G. DIDDEN<BR>
    IAN BOCZKO<BR>
    MATTHEW M. GUEST<BR>
    DAVID E. KAHAN<BR>
    DAVID K. LAM<BR>
    BENJAMIN M. ROTH<BR>
    JOSHUA A. FELTMAN<BR>
    ELAINE P. GOLIN<BR>
    EMIL A. KLEINHAUS</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">51
    WEST 52ND STREET<BR>
    NEW YORK, N.Y. 10019-6150<BR>
    TELEPHONE: (212) 403-1000<BR>
    FACSIMILE: (212) 403-2000</FONT></TD>
    <TD ROWSPAN="5" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">KARESSA
    L. CAIN<BR>
    RONALD C. CHEN<BR>
    BRADLEY R. WILSON<BR>
    GRAHAM W. MELI<BR>
    GREGORY E. PESSIN<BR>
    CARRIE M. REILLY<BR>
    MARK F. VEBLEN<BR>
    SARAH K. EDDY<BR>
    VICTOR GOLDFELD<BR>
    RANDALL W. JACKSON<BR>
    BRANDON C. PRICE<BR>
    KEVIN S. SCHWARTZ<BR>
    MICHAEL S. BENN<BR>
    ALISON Z. PREISS<BR>
    TIJANA J. DVORNIC<BR>
    JENNA E. LEVINE<BR>
    RYAN A. McLEOD<BR>
    ANITHA REDDY<BR>
    JOHN L. ROBINSON<BR>
    STEVEN WINTER<BR>
    EMILY D. JOHNSON</FONT></TD>
    <TD ROWSPAN="5" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">JACOB
    A. KLING<BR>
    RAAJ S. NARAYAN<BR>
    VIKTOR SAPEZHNIKOV<BR>
    MICHAEL J. SCHOBEL<BR>
    ELINA TETELBAUM<BR>
    ERICA E. AHO<BR>
    LAUREN M. KOFKE<BR>
    ZACHARY S. PODOLSKY<BR>
    RACHEL B. REISBERG<BR>
    MARK A. STAGLIANO<BR>
    CYNTHIA FERNANDEZ LUMERMANN<BR>
    CHRISTINA C. MA<BR>
    NOAH B. YAVITZ<BR>
    BENJAMIN S. ARFA<BR>
    NATHANIEL D. CULLERTON<BR>
    ERIC M. FEINSTEIN<BR>
    ADAM L. GOODMAN<BR>
    STEVEN R. GREEN<BR>
    MENG LU</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">GEORGE A. KATZ
    (1965&ndash;1989)<BR>
    JAMES H. FOGELSON (1967&ndash;1991)<BR>
    LEONARD M. ROSEN (1965&ndash;2014)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">OF COUNSEL</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">ANDREW
    R. BROWNSTEIN<BR>
    WAYNE M. CARLIN<BR>
    BEN M. GERMANA<BR>
    SELWYN B.GOLDBERG<BR>
    PETER C. HEIN<BR>
    JB KELLY<BR>
    JOSEPH D. LARSON<BR>
    RICHARD G. MASON<BR>
    PHILIP MINDLIN<BR>
    THEODORE N. MIRVIS<BR>
    DAVID S. NEILL<BR>
    TREVOR S. NORWITZ</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">ERIC
    S. ROBINSON<BR>
    ERIC M. ROSOF<BR>
    JOHN F. SAVARESE<BR>
    MICHAEL J. SEGAL<BR>
    WON S. SHIN<BR>
    DAVID M. SILK<BR>
    ELLIOTT V. STEIN<BR>
    LEO E. STRINE, JR.*<BR>
    PAUL VIZCARRONDO, JR.<BR>
    JEFFREY M. WINTNER<BR>
    AMY R. WOLF<BR>
    MARC WOLINSKY</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">* ADMITTED IN
    DELAWARE</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt">COUNSEL</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">DAVID
    M. ADLERSTEIN<BR>
    SUMITA AHUJA<BR>
    HEATHER D. CASTEEL<BR>
    FRANCO CASTELLI<BR>
    ANDREW J.H. CHEUNG<BR>
    PAMELA EHRENKRANZ<BR>
    ALINE R. FLODR<BR>
    KATHRYN GETTLES-ATWA<BR>
    LEDINA GOCAJ<BR>
    ADAM M. GOGOLAK</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">ANGELA
    K. HERRING<BR>
    MICHAEL W. HOLT<BR>
    DONGHWA KIM<BR>
    MARK A. KOENIG<BR>
    J. AUSTIN LYONS<BR>
    ALICIA C. McCARTHY<BR>
    JUSTIN R. ORR<BR>
    NEIL M. SNYDER<BR>
    JEFFREY A. WATIKER</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 20%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 15%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; width: 15%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; width: 15%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 15%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="margin: 0">AbbVie Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1 North Waukegan Rd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">North Chicago, Illinois 60044</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">We have acted as special counsel to AbbVie Inc.,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with the issuance and sale by the Company of $1,250,000,000 in
aggregate principal amount of the Company&rsquo;s 4.650% Senior Notes due 2028 (the &ldquo;<U>2028 Notes</U>&rdquo;), $1,000,000,000 in
aggregate principal amount of the Company&rsquo;s 4.875% Senior Notes due 2030 (the &ldquo;<U>2030 Notes</U>&rdquo;), $1,000,000,000 in
aggregate principal amount of the Company&rsquo;s 5.200% Senior Notes due 2035 (the &ldquo;<U>2035 Notes</U>&rdquo;) and $750,000,000
in aggregate principal amount of the Company&rsquo;s 5.600% Senior Notes due 2055 (the &ldquo;<U>2055 Notes</U>&rdquo; and, together with
the 2028 Notes, the 2030 Notes and the 2035 Notes, the &ldquo;<U>Notes</U>&rdquo;). The Notes were sold pursuant to an Underwriting Agreement,
dated February 18, 2025, by and among the Company and BofA Securities, Inc., J.P. Morgan Securities LLC, Morgan Stanley &amp; Co. LLC,
Barclays Capital Inc. and Mizuho Securities USA LLC, acting for themselves and as representatives of the several Underwriters named therein
(the &ldquo;<U>Underwriting Agreement</U>&rdquo;). The Notes are to be issued under that certain Indenture, dated as of November 8, 2012,
between the Company and U.S. Bank Trust Company, National Association, as successor-in-interest U.S. Bank National Association, as trustee
(the &ldquo;<U>Trustee</U>&rdquo;), as supplemented by that certain Supplemental Indenture No. 11, dated as of February 26, 2025, between
the Company and the Trustee (collectively, the &ldquo;<U>Indenture</U>&rdquo;).</P>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="tm255723d7_ex5-1img001.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AbbVie Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">February 26, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">We have examined and relied on originals or copies
certified or otherwise identified to our satisfaction of such documents, corporate records, certificates of the Company and public officials
and other instruments as we have deemed necessary or appropriate for the purposes of this letter, including (a) the registration statement
on Form S-3ASR (File No. 333-284980), filed with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) on February
14, 2025 (the &ldquo;<U>Registration Statement</U>&rdquo;), but excluding the documents incorporated therein&#894; (b) the base prospectus,
dated February 14, 2025, included in the Registration Statement, but excluding the documents incorporated therein&#894; (c) the preliminary
prospectus supplement, dated February 18, 2025, as filed with the Commission pursuant to Rule 424(b)(5) under the Securities Act of 1933,
as amended (the &ldquo;<U>Act</U>&rdquo;), but excluding the documents incorporated by reference therein&#894; (d) the final term sheet
dated February 18, 2025, as filed with the Commission pursuant to Rule 433 under the Act&#894; (e) the prospectus supplement, dated February
18, 2025, as filed with the Commission pursuant to Rule 424(b)(5) under the Act, but excluding the documents incorporated by reference
therein; (f) a copy of the Amended and Restated Certificate of Incorporation of the Company and a copy of the Third Amended and Restated
Bylaws of the Company, each as set forth in the certificate of the Secretary of the Company, dated the date hereof&#894; (g) the Indenture&#894;
(h) a copy of the Global Notes for each series of the Notes, each dated as of February 26, 2025&#894; (i) an executed copy of the Underwriting
Agreement&#894; (j) resolutions of the Board of Directors of the Company relating to the issuance of the Notes&#894; and (k) such other
corporate records, certificates and other documents and such matters of law, in each case, as we have deemed necessary or appropriate.
In such examination, we have assumed (i) the authenticity of original documents and the genuineness of all signatures&#894; (ii) the
conformity to the originals of all documents submitted to us as copies&#894; (iii) the truth, accuracy and completeness of the information,
representations and warranties contained in the agreements, records, documents, instruments and certificates we have reviewed&#894; (iv)
all Notes will be issued and sold in compliance with applicable federal and state securities laws and in the manner stated in the Registration
Statement and the Prospectus Supplement&#894; and (v) the Underwriting Agreement has been duly authorized and validly executed and delivered
by the Underwriters. We have assumed that the terms of the Notes have been established so as not to, and that the execution and delivery
by the parties thereto and the performance of such parties&rsquo; obligations under the Notes will not, breach, contravene, violate,
conflict with or constitute a default under (1) any law, rule or regulation to which any party thereto is subject (excepting the laws
of the State of New York as such laws apply to the Company)&#894; (2) any judicial or regulatory order or decree of any governmental
authority&#894; or (3) any consent, approval, license, authorization or validation of, or filing, recording or registration with any
governmental authority. We also have assumed that the Indenture and the Notes are the valid and legally binding obligation of the Trustee.
As to any facts material to the opinion expressed herein that we did not independently establish or verify, we have relied upon statements
and representations of officers and other representatives of the Company and others. We have further assumed the legal capacity of all
natural persons, the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to
original documents of all documents submitted to us as certified, facsimile, conformed, electronic or photostatic copies, and the authenticity
of the originals of such copies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">We are members of the Bar of the State of New York,
and we have not considered, and we express no opinion as to, the laws of any jurisdiction other than the laws of the State of New York
in effect on the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Based upon the foregoing, and subject to the assumptions,
limitations, qualifications, exceptions and comments set forth in this letter, we advise you that, in our opinion, the Notes, when duly
executed, authenticated, issued, delivered and paid for in accordance with the terms of the Indenture and the Underwriting Agreement,
will be valid and binding obligations of the Company, enforceable against the Company in accordance with their terms</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="tm255723d7_ex5-1img001.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AbbVie Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">February 26, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 3</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The opinion set forth above is subject to the effects
of (a) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting the enforcement
of creditors&rsquo; rights generally&#894; (b) general equitable principles (whether considered in a proceeding in equity or at law)&#894;
(c) an implied covenant of good faith and fair dealing&#894; (d) provisions of law that require that a judgment for money damages rendered
by a court in the United States be expressed only in United States dollars&#894; (e) limitations by any governmental authority that limit,
delay or prohibit the making of payments outside the United States&#894; and (f) generally applicable laws that (i) provide for the enforcement
of oral waivers or modifications where a material change of position in reliance thereon has occurred or provide that a course of performance
may operate as a waiver, (ii) limit the availability of a remedy under certain circumstances where another remedy has been elected, (iii)
limit the enforceability of provisions releasing, exculpating or exempting a party from, or requiring indemnification of a party for,
liability for its own action or inaction, to the extent the action or inaction involves negligence, gross negligence, recklessness, willful
misconduct or unlawful conduct, (iv) may, where less than all of a contract may be unenforceable, limit the enforceability of the balance
of the contract to circumstances in which the unenforceable portion is not an essential part of the agreed-upon exchange, (v) may limit
the enforceability of provisions providing for compounded interest, imposing increased interest rates or late payment charges upon delinquency
in payment or default or providing for liquidated damages or for premiums upon acceleration, or (vi) limit the waiver of rights under
usury laws. Furthermore, the manner in which any particular issue relating to the opinions would be treated in any actual court case would
depend in part on facts and circumstances particular to the case and would also depend on how the court involved chose to exercise the
wide discretionary authority generally available to it. We express no opinion as to the effect of Section 210(p) of the Dodd-Frank Wall
Street Reform and Consumer Protection Act of 2010, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">We express no opinion as to whether, or the extent
to which, the laws of any particular jurisdiction apply to the subject matter hereof, including, without limitation, the enforceability
of the governing law provisions contained in the Notes and the Indenture. We express no opinion as to the ability of another court, federal
or state, to accept jurisdiction and/or venue in the event the chosen court is unavailable for any reason, including, without limitation,
natural disaster, act of God, human health or safety reasons or otherwise (including a pandemic).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">This letter speaks only as of its date and is delivered
in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Act. We hereby consent to the filing of a copy of this
letter as an exhibit to the Company&rsquo;s Current Report on Form 8-K, filed on February 26, 2025, and to the use of our name in the
prospectus forming a part of the Registration Statement under the caption &ldquo;Validity of the Securities.&rdquo; In giving this consent,
we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">/s/ Wachtell, Lipton, Rosen &amp; Katz</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="border-bottom: Black 1pt solid; text-align: left; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>abbv-20250226.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWa2M+bOdzZR+mYkxtmB1bbmabyoif/r+Fi0BAbbGsYcG -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:abbv="http://abbvie.com/20250226" elementFormDefault="qualified" targetNamespace="http://abbvie.com/20250226">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://abbvie.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="abbv-20250226_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="abbv-20250226_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="abbv-20250226_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="abbv_SeniorNotes0.750Percentdue2027Member" name="SeniorNotes0.750Percentdue2027Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abbv_SeniorNotes2.125Percentdue2028Member" name="SeniorNotes2.125Percentdue2028Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abbv_SeniorNotes2.625Percentdue2028Member" name="SeniorNotes2.625Percentdue2028Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abbv_SeniorNotes2.125Percentdue2029Member" name="SeniorNotes2.125Percentdue2029Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abbv_SeniorNotes1.250Percentdue2031Member" name="SeniorNotes1.250Percentdue2031Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>abbv-20250226_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://abbvie.com/role/Cover" xlink:href="abbv-20250226.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://abbvie.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="loc_deiDocumentInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsTable" xlink:label="loc_deiEntityListingsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityListingsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityListingsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250226.xsd#abbv_SeniorNotes0.750Percentdue2027Member" xlink:label="loc_abbvSeniorNotes0.750Percentdue2027Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes0.750Percentdue2027Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250226.xsd#abbv_SeniorNotes2.125Percentdue2028Member" xlink:label="loc_abbvSeniorNotes2.125Percentdue2028Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes2.125Percentdue2028Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250226.xsd#abbv_SeniorNotes2.625Percentdue2028Member" xlink:label="loc_abbvSeniorNotes2.625Percentdue2028Member_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes2.625Percentdue2028Member_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250226.xsd#abbv_SeniorNotes2.125Percentdue2029Member" xlink:label="loc_abbvSeniorNotes2.125Percentdue2029Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes2.125Percentdue2029Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250226.xsd#abbv_SeniorNotes1.250Percentdue2031Member" xlink:label="loc_abbvSeniorNotes1.250Percentdue2031Member_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes1.250Percentdue2031Member_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsExchangeAxis" xlink:label="loc_deiEntityListingsExchangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityListingsTable" xlink:to="loc_deiEntityListingsExchangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ExchangeDomain" xlink:label="loc_deiExchangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiEntityListingsExchangeAxis" xlink:to="loc_deiExchangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ExchangeDomain" xlink:label="loc_deiExchangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiEntityListingsExchangeAxis" xlink:to="loc_deiExchangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/exch/2023/exch-2023.xsd#exch_XNYS" xlink:label="loc_exchXNYS_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiExchangeDomain" xlink:to="loc_exchXNYS_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/exch/2023/exch-2023.xsd#exch_XCHI" xlink:label="loc_exchXCHI_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiExchangeDomain" xlink:to="loc_exchXCHI_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentType_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentFlag_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentDescription_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentRegistrationStatement_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAnnualReport_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentQuarterlyReport_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentTransitionReport_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyReport_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodStartDate_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFileNumber_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityRegistrantName_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPrimarySicNumber_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine2_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine3_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCountry_90" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_90" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCountryRegion_90" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCityAreaCode_90" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiLocalPhoneNumber_90" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiExtension_90" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiWrittenCommunications_90" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSolicitingMaterial_90" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer_90" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_90" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12bTitle_90" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiNoTradingSymbolFlag_90" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiTradingSymbol_90" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityExchangeName_90" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12gTitle_90" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityReportingObligation_90" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAnnualInformationForm_90" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_90" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_90" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityVoluntaryFilers_90" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_90" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_90" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFilerCategory_90" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntitySmallBusiness_90" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_90" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityExTransitionPeriod_90" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAccountingStandard_90" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_90" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityShellCompany_90" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPublicFloat_90" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_90" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_90" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_90" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>abbv-20250226_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsExchangeAxis" xlink:label="dei_EntityListingsExchangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityListingsExchangeAxis" xlink:to="dei_EntityListingsExchangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityListingsExchangeAxis_lbl" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/exch/2023/exch-2023.xsd#exch_XNYS" xlink:label="exch_XNYS" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="exch_XNYS" xlink:to="exch_XNYS_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="exch_XNYS_lbl" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/exch/2023/exch-2023.xsd#exch_XCHI" xlink:label="exch_XCHI" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="exch_XCHI" xlink:to="exch_XCHI_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="exch_XCHI_lbl" xml:lang="en-US">NYSE CHICAGO, INC. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abbv-20250226.xsd#abbv_SeniorNotes0.750Percentdue2027Member" xlink:label="abbv_SeniorNotes0.750Percentdue2027Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abbv_SeniorNotes0.750Percentdue2027Member" xlink:to="abbv_SeniorNotes0.750Percentdue2027Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abbv_SeniorNotes0.750Percentdue2027Member_lbl" xml:lang="en-US">Senior Notes 0. 750 Percentdue 2027 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abbv-20250226.xsd#abbv_SeniorNotes2.125Percentdue2028Member" xlink:label="abbv_SeniorNotes2.125Percentdue2028Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abbv_SeniorNotes2.125Percentdue2028Member" xlink:to="abbv_SeniorNotes2.125Percentdue2028Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abbv_SeniorNotes2.125Percentdue2028Member_lbl" xml:lang="en-US">Senior Notes 2. 125 Percentdue 2028 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abbv-20250226.xsd#abbv_SeniorNotes2.625Percentdue2028Member" xlink:label="abbv_SeniorNotes2.625Percentdue2028Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abbv_SeniorNotes2.625Percentdue2028Member" xlink:to="abbv_SeniorNotes2.625Percentdue2028Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abbv_SeniorNotes2.625Percentdue2028Member_lbl" xml:lang="en-US">Senior Notes 2. 625 Percentdue 2028 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abbv-20250226.xsd#abbv_SeniorNotes2.125Percentdue2029Member" xlink:label="abbv_SeniorNotes2.125Percentdue2029Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abbv_SeniorNotes2.125Percentdue2029Member" xlink:to="abbv_SeniorNotes2.125Percentdue2029Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abbv_SeniorNotes2.125Percentdue2029Member_lbl" xml:lang="en-US">Senior Notes 2. 125 Percentdue 2029 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abbv-20250226.xsd#abbv_SeniorNotes1.250Percentdue2031Member" xlink:label="abbv_SeniorNotes1.250Percentdue2031Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abbv_SeniorNotes1.250Percentdue2031Member" xlink:to="abbv_SeniorNotes1.250Percentdue2031Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abbv_SeniorNotes1.250Percentdue2031Member_lbl" xml:lang="en-US">Senior Notes 1. 250 Percentdue 2031 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsTable" xlink:label="dei_EntityListingsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityListingsTable" xlink:to="dei_EntityListingsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityListingsTable_lbl" xml:lang="en-US">Entity Listings [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentInformationLineItems_lbl" xml:lang="en-US">Document Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>abbv-20250226_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://abbvie.com/role/Cover" xlink:href="abbv-20250226.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://abbvie.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsTable" xlink:label="loc_deiEntityListingsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityListingsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="loc_deiDocumentInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityListingsTable" xlink:to="loc_deiDocumentInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityListingsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250226.xsd#abbv_SeniorNotes0.750Percentdue2027Member" xlink:label="loc_abbvSeniorNotes0.750Percentdue2027Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes0.750Percentdue2027Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250226.xsd#abbv_SeniorNotes2.125Percentdue2028Member" xlink:label="loc_abbvSeniorNotes2.125Percentdue2028Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes2.125Percentdue2028Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250226.xsd#abbv_SeniorNotes2.625Percentdue2028Member" xlink:label="loc_abbvSeniorNotes2.625Percentdue2028Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes2.625Percentdue2028Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250226.xsd#abbv_SeniorNotes2.125Percentdue2029Member" xlink:label="loc_abbvSeniorNotes2.125Percentdue2029Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes2.125Percentdue2029Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abbv-20250226.xsd#abbv_SeniorNotes1.250Percentdue2031Member" xlink:label="loc_abbvSeniorNotes1.250Percentdue2031Member" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes1.250Percentdue2031Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsExchangeAxis" xlink:label="loc_deiEntityListingsExchangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityListingsTable" xlink:to="loc_deiEntityListingsExchangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ExchangeDomain" xlink:label="loc_deiExchangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityListingsExchangeAxis" xlink:to="loc_deiExchangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/exch/2023/exch-2023.xsd#exch_XNYS" xlink:label="loc_exchXNYS" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiExchangeDomain" xlink:to="loc_exchXNYS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/exch/2023/exch-2023.xsd#exch_XCHI" xlink:label="loc_exchXCHI" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiExchangeDomain" xlink:to="loc_exchXCHI" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm255723d7_ex5-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm255723d7_ex5-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  2 5X# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^H[XG?''X
MR_L]_P#!5[]F[P%XN^(NLZU^RA^W-\&OB9\-_ /@K5+#PM!H/PH_:R^"&G6'
MQ)LDL?$%MHEIXD>'XQ_":W\8K:Z=KFO:I;2^)?"S6^E6]K-?6-JWR)^RW_P4
M2^/7Q._X+;?M;_LW^,-5N)_V-M;TSQ_\(?V3XKG3M"ATW_AH3]C32/@\_P"U
M7I>GZM9Z1;:SJ=S/JGQ:U)M3M]3UG58K1/#(M--M[.6PUJ.'[/\ ^"Q'P(^)
M'Q8_8SU7X@_ +PW/XJ_:=_9%^)OPP_;*_9LT6QL;J_U/7OB9^S]XJL?%-[X(
MLK#3\ZEJDOQ*^'@\:_#I=&L"LFKS^)K:U>*Y4BUE_'#XO?LP_MC?!;_@D/\
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M:=JMW 8##,LKI(LDF_\ \$4_AW\0?A;_ ,$\OAQX+^*'A#Q7X \7:?\ &/\
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MXHUOPG\.O$&I^(T\0?%_X%7NJZ;\7?AU96J0QZPGAK6M(U"UU=+JSMH_NO\
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M&7Q>L;KXJ?#3PK\7?!:>'?V5OVH/'(O/ OC5[U/#U]JDW@GX0>((_#6JW/\
M9]T;KPMXC73?$^EYM_[3TFW\U!+[/^Q?^WO^RO\ \% / OB;XC?LI?$]_BAX
M3\'>)I/!_B:_G\%^.O UYHOB2.W6ZDTF\TCQ[X:\,ZF9TA.]GM[2>"+_ %$L
MRW4<L2?DG_P6 _;#_:.L_BOX4_8C\ ? C]OWPK^SGXW\'P>*_P!IO]L3]D/]
MGKQ9\8O'^H^"[^66U_X4!^SSJOAG=IG@/QQXQACNK3QW\7M?N8]5^'V@M.G@
M_P ,ZKK-]9:IIGZ*?\$SOBS\!?&'P5G^$_[-O[)'[27['OPH^ *>'_!GAOX?
M?M"_L_\ B/X"?;[35+*\U'[?X+M?$M[J%_XSAAN(+I?%/B26[NKN;7;@RW]W
M>7-V;AP#](" >H!QTS1@>G^>?\3^9HHH 3 ]!V[>F,?E@8^@]*7^G2BB@
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83  P  ,8Q@8QSQ].3^9HHH 6BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46378254317792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 26, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 26,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35565<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ABBVIE
INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001551152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">32-0375147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1
North Waukegan Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">North
Chicago<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">60064-6400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">932-7900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.01 Par Value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | NYSE CHICAGO, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 Par Value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">CHX<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes0.750Percentdue2027Member', window );">Senior Notes 0. 750 Percentdue 2027 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.750%
    Senior Notes due 2027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2028Member', window );">Senior Notes 2. 125 Percentdue 2028 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.125%
    Senior Notes Due 2028<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.625Percentdue2028Member', window );">Senior Notes 2. 625 Percentdue 2028 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.625%
    Senior Notes Due 2028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV28B<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2029Member', window );">Senior Notes 2. 125 Percentdue 2029 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.125%
    Senior Notes due 2029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes1.250Percentdue2031Member', window );">Senior Notes 1. 250 Percentdue 2031 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.250%
    Senior Notes due 2031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNYS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNYS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XCHI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XCHI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes0.750Percentdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes0.750Percentdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.625Percentdue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.625Percentdue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes1.250Percentdue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes1.250Percentdue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M87HX%-E\Z06K'R[)Q6BT(GZXGLT9-1B@>*/^R5DOSV?@S&;0(FLU:!! UT)
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M2_R==S Y8\0#.I3OW/1W!R;Q&-#C%<K<9":)-5U>B/%*0:S;%4S.Y68R#/;
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M>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ DHA:6F60>9(9 0  SP,  !,
M  !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !
M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB
M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G
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M+GAM;%!+ 0(4 Q0    ( )*(6EJ)K)K"[P   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( )*(6EJ97)PC$ 8
M )PG   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ DHA:6DQ=^+Q4!@  6R8  !@              ("!#@@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( )*(6EJ?H!OPL0(
M .(,   -              "  9@.  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  .P5      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>8</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>8</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm255723d7_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abbvie.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>abbv-20250226.xsd</File>
    <File>abbv-20250226_def.xml</File>
    <File>abbv-20250226_lab.xml</File>
    <File>abbv-20250226_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm255723d7_8k.htm">tm255723d7_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm255723d7_8k.htm": {
   "nsprefix": "abbv",
   "nsuri": "http://abbvie.com/20250226",
   "dts": {
    "schema": {
     "local": [
      "abbv-20250226.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "abbv-20250226_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "abbv-20250226_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "abbv-20250226_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm255723d7_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 3,
   "memberCustom": 5,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 8,
   "entityCount": 1,
   "segmentCount": 8,
   "elementCount": 73,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 40
   },
   "report": {
    "R1": {
     "role": "http://abbvie.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-26",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm255723d7_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-26",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm255723d7_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "abbv_SeniorNotes0.750Percentdue2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://abbvie.com/20250226",
     "localname": "SeniorNotes0.750Percentdue2027Member",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Notes 0. 750 Percentdue 2027 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "abbv_SeniorNotes1.250Percentdue2031Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://abbvie.com/20250226",
     "localname": "SeniorNotes1.250Percentdue2031Member",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Notes 1. 250 Percentdue 2031 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "abbv_SeniorNotes2.125Percentdue2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://abbvie.com/20250226",
     "localname": "SeniorNotes2.125Percentdue2028Member",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Notes 2. 125 Percentdue 2028 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "abbv_SeniorNotes2.125Percentdue2029Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://abbvie.com/20250226",
     "localname": "SeniorNotes2.125Percentdue2029Member",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Notes 2. 125 Percentdue 2029 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "abbv_SeniorNotes2.625Percentdue2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://abbvie.com/20250226",
     "localname": "SeniorNotes2.625Percentdue2028Member",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Notes 2. 625 Percentdue 2028 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "exch_XCHI": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/exch/2023",
     "localname": "XCHI",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NYSE CHICAGO, INC. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "exch_XNYS": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/exch/2023",
     "localname": "XNYS",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW YORK STOCK EXCHANGE, INC. [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001104659-25-017490-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-017490-xbrl.zip
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M'M3"48JZ V\413$6ARI2\?)/%W,(H#J.TM4Q#F+5=*Y[_>F#?NT8T#;M6'G
MOA$RR+:C%/6&/PBDWY,Z7B^GG,*;D@R&'G .H09I=Y2-EE"9"2^9>$!U%2](
MLJ-L-+_A\NV7\-H2DZ4'E(.P0>8=9:G;IFY>JPV?^]>&SVNTX8ZRU!Q4NM%
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MR>'@YQ>'_. NX-.5Y89P[<_:T7Z/.!M-OG<U!!*=@YPCLZ]3%:DL%,E8=#A
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MBW?=S9[6"QH!V:>T*EL0&"P6'&@D7J  ^VIDK*<HEZ),ZR([5<VLICK*>EL
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M*+VP_1ZQ!Y$NDVA](WB$L7YZ)+?7(B O Q8 52B<K/E%S/B9TWC^KPKCN>)
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M%<K&\=*4CU>;^-S0^].)IY\>43L^/E3>UQY=??]8T?M]76M8>OOIBO5;S'#
M!%J+"I(2 ,WY(6VPMFT K(+8:J+RBY><$0@?XI#\.YU,"^26&N0C5>T5$;99
MN/-^N)L&13>K,>ZW=#5>*I^>?@R#+>7G(X348!UF@)/&3/X<#>^1R3TJ@)AP
M-^FH9R#PJ%P3GF),CDPY[CY&H_<V;BJ@,ACJ?7>:P,C.5*9N&^Y,T(A+TI&+
M'[ZZ&89RK9'7DG$F\GZ<_*S(^*"C,(-PP%FH<U*I703Y;;;S9+)4V&SN7 -
MI"[/@0#NH6&=@;XL3:'WQID^F^T%XA?1QWLR Y)_=N\W%WV1*(UDN4A&<YGQ
M^G/CYQ!@BE761?4T_=U](@,DHX&JM!7+@9C("C3DFXZXNZRCA@4(Q.X5E9K
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M54!T@*],YCLS?*V4HV6G<FQK)BH\Q"U\M'$OC2^J!;:95ISD,_JDBT]KH$C
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MS$J0>M$$<]IL\9DC$YR7]MCE8O3CY"**I=Q-95H%%#H81\/<W 591P)N\DJ
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MZWF?WK=/VD=O_:HP+V52$I72:'[]"9MP+LUQH ]C!'C <_@Z1/B-* 4S-!B
MP:P8,^[13>^WWGQH>WAS>=PZ/.QTW_WKR?83^G?ON'6@_JVDA[?($)1',,U
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M!6])]EYY1U1PG[W$AJ5D4)>/K%P>6.OISM-O*B&IK2!97\M\OW-P;#2?:SG
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MHJGB_+Z" *T(//G*,HYFJ0IU:DHT0YA5^)U9).OMN6,34 V6.;:D9 K&1.0
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M7[L:2WS@@._9;&HBK &C)(BLY!NKV[NY=27&I<;2$JDLV?0]*2Z3C*%!J#[
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MWB0 )'%X(7GS6GNEI;[=7>'F H<'9[;<+#W7_B(WCRLG/GVC"Z3.!X/EG'K
ME_0L6YR-0.' HKA99CNMDO$NX#@>CN$0ON2;@$'$'ET1_@1F=D"7F# $\']
M&81IFJP>M@Q8P/6W$I1;5110$KY?=C$+@7Q.-%84<)>^P)";%78+,S;74/H+
MMR !H>J.*3S7OY@#=+UAP;2/^*$@O<;\I<)JEF]:C-^(AW1-:'@*7LE0)9!,
MTP3.'TJ7*:L*\_:56VL3T:\T-TN1?3RVKAT(4GT2,J!H#S4J?(P)2#%^3?*
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ME&5P@J.6<=B5+MIGE/.LU[T<)RP$-XMDRX'WCB.M>"OE*[?!-E6<W\N-OM/
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MR%^U:4!1(+4E=;A8M^+K):<ZS)A*1B-3XRH[H5K\5^[(.**:&<9X*&W*TJF
M1=@W'PO?<Q!X%>> UMF6L&(9V4W26CRM!B$J"R6LK ?FK+7WDRWU-X->&/,:
MI*/9T.)AF=6$*)853/8=E;(L<!4;I;)_-.;T249*V[5;Z,A /U2IW?GJ:'/E
MUL1VNZPSJC2S#*:,V\_4Y,77I<.W )A6W)8X>]<8=,%JMW$T-* %9I.XY?=E
M!&'M,SD@P*8VWO#!YU>(CI$&YVDPO<@8.<,]B1?MA:Z/*W4'8:?$G285]NSE
MSCXOW'1KLN73VGQ.TB_> 9&*D0.O]1T9**R.,IX7PD$@3_H\ 0^$D;*MZ :Z
M+=.$H*Q& 6P=-2EODB =D32^H]\EQH]Z"TN4$A@!# TLE-XU_'RRZ2M?!4:=
MCDP_;<P*M.&&X4C;4L75!OM% 7^9E4U@A\I8%'2#C?""UA%7VW)):W$F%.K
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MDZ#H'BJD=YQ<LX".!W0/J\AL+,7IYBOHMZNT9WW>X,6#@?=N-JP\:)=M ,-
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M?!:IL$D089?2 B^BR3TFMJ[V ;)@DL+W9([,SR10F0+/;G^.S?>A[+OWN]+
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MJS8-* JDMJ3&#G/2?;WD5&,54SE89.K79"=4B__*'1E'E _/]=NE35DZ%;#
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M$L/^0Q4S>5-AGKYQ<VTR^H7N9BZSC]O6#P?65.^$#%+:18L*'V,-T@2_)GU
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MYHY&):$AS&&PT,DP3E(J+J-S-4PLX>,C88OS%/ZWA35JOTLT87;+% O71L'
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M6,M51%-TRF(_UCD^NEKW[H:\X2+XU+MYN5M^H=)6IH*NM2I%^A7'=.-.GL5
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MES1*BT]F?2$7:1J/J\P7QW6S),!4U9,QV#85V:&A$V4E- MO,D?? 2T%@B3
M.DRUY1,!$_ *!?D&&#N=CV=E 3^KPM/KJ@++RA$_W(_EA:% H<#L758M%WR1
M<:6)(:"+=%:L< V$U34-?K*[@R^L-EF_=.T7/#&Q39-Y6;W3DI>,77#81QAD
M7#%G62B@DWK-3*%X<_ 4#-?3C''Q-2S'@A$:*V'";7KZ&GMYU8XC]W<>WG'D
M_N-QY"I;X497\B>E.3SC4/J>\BW$1,K6H!T\-R/ M@(\0:1/F(4+_0[Q555K
M,R7B^-0.3(9K3>PD("+'7"+$TDPL*ERC[0,XL;N[KW=VO*#$U=<^-CAJ2!EQ
M+:$40T[HETO522D/"].1$P+OH8#(,ILJYC46WB]*N> QG1$B^';NIG6%412D
M_OMS26OP^0MX+NHLM?B^(!'CXF9?R.P#X$0,(S;>"J:MU"'PR7LIO)>)=G(C
M9^^C])=6S+DXB67[NY5F-?.X>FW92*T9JR9C.XI8/'OH3)C;U6L5[F=1B S@
M,S G@75"H&)+-/]@BQ>(BJ95GYNFX54'4D74:H& KTC#LEPA<'"RP2XX)8D<
M!>$_^XB$1P>+Z=>0(%P0$5D#NRT?X5)CLL9.1\F64#TJ]!!GNRB9P\>[*HV4
M\3-M0YVWSC(QUB.7*0!I'!Y)+I]K+S?55SLMW*ZP>7!ERW+M^>%7.7O<./7I
M&5N@"6X#@9CA0WK6+:Y&H'1@5MTLMYUFR407L!T/QK )7_)90#_BB"Z+80*2
M[:?,JCJ!^ >,09@D\>8!Q( '7'XN0;55604EY?MU#^L0*.9$9T6A;^DC##E;
MX; P97<-M3]S#A(0-.Z8TG.]\P5HU5L6UOJ0+PJ2'UB_E)G-_%F+B1MQDRY)
M#4\A*AFH I)I$L/^0^4R>5-AGKYQ<VTR^H7N9BZSC]O6#P='5.^$C K:18L*
M'V,!T@2_)GU )+-SC/(X3ZN>95DR]IBD+(?0:!-J@.T'DZ^L%/$T)*XLC:I)
MJSA_JXV;@]["@\!A3)(5R"X4 -:?@ 2^D@T"(6_<"[<1R,]K70KBG&"=YG#5
M%ASE\P*.!W !FV0RTN ]SD$H6>#JI6>MFL]M, ZP[1%YA6C1"_"L.ED@X%)V
MW+25$*0J&TW8*2?<N,GIV:,GJ0;1)+41O$9T3C$"OX()ZNRS<I$U5L@EA,@=
M]L$9F6AL0(>C/"$8K( Z3M,9[+E4/3B(03$"+/&AIO=+5>U3IB;.31F-D8"M
M"26/O#(P)V"KC7573\4P.V(?P>"9S80?P!.\T]3;?=K8H[' 7Y[F25UP(] \
M%.4ZN\:*4#$-N/OPTH#/']. =V9JINB-SZ1V0*]1YL5AISU(U>KT#,HI^6)8
M_\Y 60)VJ<J$+^(AP^Q9CB#7(;/'P0!VJD+9SBBH.\C5#BRD*5%T-Q6R.TZU
M64#; X:'1>00EN%TZQ7TTU79L]YO\.#!P.76:U8=M(O>C6F@_\:*K*I" 9*-
M1'LRGV&&;"@%B^7OQ742^I5@CL;@VA?M&CR].L%CC=M@;)HP.+W9H&E^&#><
M:TE@]OLA. VCS$12/#,>9^:1XFA=AA)[WP+>F/0VDIDM1V.M=\:B@LR4P[SJ
M"P.(9H:\JZ6E["'P2<0%I&)]4@MK7VM#PF-,7!3<W)ZKSM#+@UJ#C"ZWT'#I
M!-LYIW$YQ?<.WQ;7VML42I[-H,21F6%1XG6D\%YE[6:8E/!3=#DL,B4#,NIP
M$L ?O=!+Q*.XC&0T=T-8OK(PW31IB%D4+\0!["SK9!&2-:VNA0Y:SMO)W-#Z
M1K"<QX+8','2B%BAC9759DOW=@CU28JYDW@\%^C@^43[9L'85RPL.;=>$U8Q
M1+A;!I[# [=L!0B:$EWLS">!PFU6 ,L9(&_?T]N.8JW;.'5IIN5!"KU[.N__
M5UQJL5!"W2?[H]IZM:LL%26EY'L6-X8=1N40E'UE=%#8Q59K$95;56AWX:*@
M>6>BC"LK%%IS1Z.2T##4,#KG9!@G*167T;D:)I;P\9'0LWD*<-L"][3?)9HP
MG62*A6NC8&#3#%J^ 6\K!73C#D0H#<+:#8Q]);9Z<#R32?@CWRDYH5%2)"T[
M4!+2%-G]C!/0Q>5=5^/H*^;E)T3,,[*? JH7ZX0LUUBK^A,BMBOM?/)U:E%V
M%M7M8",9B3Q#/H?2_UKG*.PZR:$@82G0^D+230I_+48:S4T:SV=@UG 6R;5R
MI6^RMVH!H-*?8>GC!3@GT90IM'[=I6O$*T]3Y6V#0Y(S+MF=)F]=O"7&9?%;
MYYA, ]:U KT!(Z_=QP4WS2JLM!%'(]IC9V6ZZ^<X&*T5IVT:^:1*N3=."<'5
MP )8-*\@]>0LS&#J*_#O<M<.+C"$FVR7B</;5Z?\VKJ)$2BP;=SI1^P\-F%%
M0)UDZ1S-?R1@R9A#XB&I$8#T@^\X5RDH+G60,:T<Z"!2")@Z6=!Y>4<K_0?>
MR(330:RIY/ [)+3*(]=O#(^C(R'S0.MY]=JB!Y*MM?E)]4VG\P06^T2E1WGM
MO&H\QXMV=QLO<O[:YO48?%0=%9B%E<9 0Q!C[[Y9I\#1.*<\(-]"3/OHF<4[
MDU$_$W>#FL^P]9)+')93AV&)HT.FR,Z)Q5-J2+^$6(9:])#B @,PW>"HMD3*
M=).FF8/&3.#CC@!6)2H7R,]G_W8B'6.E$IF8DNYS$8M>X#J# 99-R+)DP\4H
M/]G$0Z\FSBFW@J=JPW*(@R@FP5U&=QX7>LP+ R%-:"%LX*GP:FJ'Y:+8#2^^
MZ<;)N'?4[FIH$:][U#P^]MZVO/<G?[9..ZU#Y/QM=A#CK=/MG7YJ'2+)J]<\
M.#@Y/6QV#EH(E7_D]8Y:WG'S<Q=A2O#OW9Y@='9:G[TO)Z?_6F.Q5$RJ[SV\
MI/J+QZ3Z72+B!-[;./[ZI 7&VLK*,: K>^IBH?+)GA**8@Z+%]&7!QGZK$"3
M9V6^+,+,R+GVEM.^Z)%3WIPMKVQVOHC'"^,E=1>*1>"F@R@9S"\PC3S H':H
MTCW%MAH]4J'147X'CHS/++BRBUN+\YQB1/ME"24_5$H7:,ZP_"6R"V<$+04Q
MI7=>8XM9#%WU^V]_>[GW]-6;V_U?"0C@W3YL?:>BXN;U].%M7B\?-Z_5XM39
M:.R]$_09#UO';? :P6G\]/&DX[7^?7#4[+QO(=1SO79RZIVVWK?!B20 :/(4
M3YN=[KO6J05NUVYUUQO=3O;M XL6CED.Z<#UUW]^^F-UE@F+_(HA*JR-ETHR
M81/<8O)$J_HQG0:#<-O#(2X$6,7'P%('5R0D5P1VJP6_X4$-#;\E93)A3URI
M**[W7QZKW>M+" GL$,2)C>>V_MMO0?[9O(J:?CP(Z,??/0;D6B$@534D_<_M
MP][1__U"./G7'<&2_6(!%##\D-'YLXC?"LN$X&E+ORU%.OD,/CF>R:<5+_KM
M;[O/7QHP7@L:%_Z<.UEJ._D#:TH=2M$^3+DWQK1SSN%'XCXS0205Y^JC,?&.
MSY@'5P<9JH[;=4&Q?M4^8[:L#)U,J"7OYPXR%IT@,7#> L \W;;GO@3F=LQ;
M4 8L^QI;*E\7)R8%'"-5\E#A /;CRY!Z^0T6\6J1B!\7!B\,4?-KK(]K+0P[
M*Z^T,W<,7J;>C;M7#EL9LLIR79A]U";MM.=I2Y8R)HI:%#!EZ/<H A)?%B58
MOZU";7;-460I3PSCB8-6?DW\JH([_=7N=,$E]CK-#RW;NSTY+8(_O\U7OCV)
MEH*ZWYZ8F.FG$(E^Q9IQP]N[MN_YWPO>;9$^:I:/E2IA*4=+I;5I"#IV_U[I
M;8@JI42L13.SMWQFEDR7-L?KYY=7S,4\>WBYF%>/N9C5YF*Z!T>MPT_'M.^H
MM,N:)U+*HU@#NZ"<N-2WVD2I/&,Z3^"K5.K9 FI8U84'1<<H=,K;1[!\+(2Y
MDT!X'5VZ9=Q7>WA[Y3I11P58K,:+?5P^\IN;3WRAZ0(%L(S76_(36+3QB#.(
M^/26:,0_S$<&6,7Y4&F(6@4+]['RU\YRY]VZ,(J,<24!-2E:SHMH& X02B!4
MD-/FFX\JTN:O^ ;FZWBD</FBE/]F%I*Y2JVH!R=7D-VMRM52:I0P?W/OI7NK
M.LA7Z/W"7(#9(?[270U;<9*?T.U[*^PNU5G/DP)#:M)SEM3H\ECIHGVY9F^Q
M)%6=EQR&"\,[(RP3W+7BY+67G/6W]G:>^7M/7_I[^_O;!7M2B;2O%'9=8<8>
M[US]SC>;^\_GT2Q\G/!-NO/C8G^X=[Y/V9?]AY=]V=UY3+^L-OW2[';;[SL?
M6IV>A^2-ZYUX^>6/7BPE[AE(%F\4$0PWG9-Q&0>6#:PQC=4O?[2I9SQ4+T1M
MD+JSQZFPG<6/29_BT,:Y_T+*]B6&[*9G>]5-YFV>F6QA3$K8 S.PHZK[(]3P
MA%BX['NP:R(0)&G8_Z(I2'^(D>.-#O:N\K[7\L4*'O9PI[D]26%<^?E-XT$#
M43<;I +!=Z_=.&P@?VC)]*ZU$T05_TD27L98]/<#Z_^0BFYEU7@_J<*/*_FP
M</],.DE+K+Y@F6 Y8Q8YB"%Q^ ;8()#.^^DLFC&TA30GQ A.2A55Y]'%"FL"
M-WL#*3P,O]V2@<7'VNK8^MG5][$;GW-?66A7&D"EBV\^-.N$_@YJ0+[$\\33
MR<G?;Z<:9*/DO7H9W[02Y-X(@L+A1U'@G7K1;/SS9+'&?E.Q[XD62C-V(9<?
MFBUJ8V26NU1Y%^0LU&LIXOYFT0\>K--04CZ'J?\GU(KRVIO$WY)@:IZXOUH_
MXG>]Y7COYP'XB[.PK!0Q6[6W?^>.Q1JO%I!DYZ37/FB])@\ZU5)5(+\<8A$8
MR 4BP1L^.8V/6:_Q0DJ]:*:7DX8>'"'TEWCKT@"-*#34Y@!Z]H/J?2(D"$I\
MC9I$B'8!0_V$DS$BM5P(J"!AH7,]^+=S\";A'@VO.Q^<XZ)5HZ>A]D/O3.L&
MM?9JGL80]#K"1BJY@' ..6* 9QKT=4..(B XF@>]&"]'L/40C<2Z/$+4QR&B
M4B#W67H>3:GNB=X[FM)KHCCT[53OC]<\H]]_"(?!>,Q\Q_%9$EQHIL=NK_GA
MHZ:E5%PF'/#()5HH]9J6!@)'X7W4BP86'G>6S;4 % C;/H:,%$@D18P2J6,N
M_'B$X&,T.I_ 5!R\_WI-0ZM:?2BJ'LAK#JC^:_?5TV=,"H=(LVN-_E?QP.+Y
M&^^$Z]Y>>\<(1/I03BUVJY]:_(0C!'W9BB[YQ]N3PR]H_?]QU/MP_,?_ U!+
M P04    " "2B%I:CXQC7<88  #N7   %    '1M,C4U-S(S9#=?97@U+3$N
M:'1M[5QK4^/&MOU.%?^A+_=D"DX9#^8QF0>A2K8%%@B9D@T4\^66L-N@C"TY
MD@SC_/J[]NZ6U++-S$ F)Y-3.9638*G5O7N_UMJ[91]V^N?NT?K:8<>VVOBO
MH/\=]IV^:Q\=OE;_Q=W7^O9AL]N^$;W^C6O_LC&*H^R]:.Q,,]$/)S(5GGP4
M?CP)HIJZ4!,]F82C#3R(1R_RYR9!<A=&[\7.QM&KZ#:=?CA\??'4D \BDY^S
M[6 <WN%C$M[=9QM'A\TC^_-]>!MFXJ#>.'S=//K"#$\O8LX\D%$FDP]"/;:=
MQ5->7'^\C;,LGO!DA\[YB>CY+3P^V3TX^'EW;_CS_\G/!]N-<'*WL].H_SJ]
MVQ"6V_]E8Z,4JV\U75NT;-?M75@MQSOY96-G@S]?6.UV_OF9>OT@'L-A=D]#
M=W[Z(&[C9"B3[4$\'@?35&)/^J\-MNMAW]?V/>RW1:M+DGB_;+PIEIT&PV$8
MW:F][TVS#R*_PFI_#UWOFU?'<I1?Q$Z/NU[?W,!V&OX.&=[2S=P -(:\JDW_
M\G.I\J<>9)*%@V"<FP1R;!@2^]UK)?'!DL0ODF\43,+Q_/W75+RXEW/+[SN>
M$LMU+OI=[["9*[9C^TW;[XOSNKBV6IT^S%O>M-O7EM\6[3H-<YW.37FK;7F.
M[0JK+CS[^+B\WNO;5[9'U_UNS_::[N6Y<;/5[??%65VT.I;OVKWRSFFW[8C3
M.D9TL&3_8WG':EOGHEL7]OFY[3NM3GG'M]R+#@GNTI*V<:/;=#P!Q7>OSBQ3
MY"NG39*=6>8"CHN'Q9G'[GX" 0VQ+*_MV]<DF'?9ZS4M<S,^U 5MV:+GN%>L
MQ9-5:FAU.[:A[[;=[/I61[AU"'CI+DK7(NG\"V,5AW35)J6=.>>FPGJ=2TOX
M6, Z/[?.;+^\!WN?82=^VS3TJ6UYGHU;CBVZKY+TMUG\H8D/GNGC/YSK0H\7
MT)_615VTPPO?.3>,ZD$_7=?JB1/<A(]T#<-"!5":?VZ9:NAZ5K]C>>0WY_!0
MP]A].)ESUH78EG=BN-.UX[H.G+ '"_7[Y?43W\8*-\*NBVZO[R(C+EJS62</
MLOW>@CN3HW>L"\<WI/5LM]?UR-./G8H/:DM#7FSTW!18+6*OF R+.-@CZ<1I
MMTW_H\O-;NOC6=?TEWZ_ S?'$B>7=J^_8H4SJV-J45V'3[J6X9--VSO%PJQ;
MO]OO+.T!X7!LN_V*06S7<A!_%UB["QT:-\X=SB]GKNUX'>NRM]I1"U38?;ZC
M5I%:X>EW=-Z#AG8@Z%0<['IM3.K;=M\T^K6XZ?IG->'5;^H$BHUWVV\:!SN&
M5]HN0J#KV>_%YFYC=TOL[^QM8Z QY-AJ]1QHJS)DEX;\R*&-/&?W>I:&)<IC
MIO5]Q*G+^;!5R9]-WVJ[]@WE L1ES\QP)\BK"*YK!+;M.BOC] (KFJNT+)_R
M(?FKC2B_6<BAQW5Q90,6C"=Z%F5O>+[=;AO#KYQ6']D&+MR&A[=-E/#:ENN2
M5*=6ZZPB<)-N(N:Q262UEI%RSNPKA%%O%1Z>$R  >7$3\6;,9KD.)9"/-)GM
M],S$YIQ:GD59IWW5]9$Q353P<,=F#'4J&'IC,7R=#UR[:^P'L(_T"755MG_:
M[7AD0T;>RAXU$%X[7M^$* KN&R(6]"0]\"-[*@S7;>KM4SZJ9'K?LD[)&!X<
MX\9,;%?.&;E$S[JP/W8\ ,O5LA$5X^DV;9-T87X+88_ KQ(.HC]L*ZMC)&_7
MNO1M3KEGW>,SPX(?+6(.-R3;1;>-+'EV8TI-Y(4 BGREREW8];%1X. )@,\S
M%FO=>/V.8R&+^QXAVT<!?F<3PII!U?&=7I\V <>N8'47H8,E;PA(#9<N< .B
M6OZQ^01C-1%-N$KK$FS+K[!74@EM_1@0 4\S0YN!UB54Z;8K@*,]$@D$B<$,
M[7/;.\%^_B#G?S8>Y87:P=..?/'\,JNH)3%TYUMQ[NGZ1]>$_[.]+8Y#.1Z^
M%_YL++<O@CLIMK>/#MO.5;6*U3L(9EE<E*1Z_^J:K@-W#W[:J#QN"-(@C>@2
MD2N\YC@8?*++(HW'X?!Y6\ :^;^-;;RN[*-:;']?;;,.V4M^#'/^5:*<V%W_
MQ,[K,"7'9N/=FX-7T3!([S\TWKU]MV5 BP7.*SJ(\>Z)HL@T^.=B\+N&,1A8
MY5&U=*[+S\K$NSN-_:T?0@7_!-<_P?7GB-(]!@!=>CT0BE*<ET+97TBY5..E
M*/N;8(*+ ']MW7A,W4'B*X5C4]&A$^8E!IF 4JYO4/W6B:57*<\%V)9/=*53
M6>*T"29>*0M0R*(:(S;B6GZ%Z.:-FA/B/)4[%QW'=2[ ^;QV14[4W.!EOHW:
M#S?]*V>IM"=:276)\8QO7Q&IQ(VN?TTL:B5Q_@LM1Y1,ZWM5/9 S-J3G[K&I
M5Q00*+=ZUA65A?9JJFR?6(8NKKNJ1.HX2YT)+-!SW#.35+L.]1ZOB-96; S(
MX!9*WT?]4Q.G?OW?ANFL2Q=$_B/5B5W4:GS?K)Z.CWT4H]0\18'CF16.=:Z*
MU*YK;!/4ND67H!2P\7^(YH^5//^-HN'<Z??MMLC;Y6W;M5" VS^$?'\/VI!+
M^5=3@B]I\D<UYU\ERG\%9^#4K_-L75";T%_(];U+A+<EK,[EJ<$+.K8%*/:Y
MQ6#A";,9<^Q;7JNKKKMF4[$X&>IPA_+2; E=H&1Q+6%W?-L[PP3F:99+S6[@
MPK';;1MH@5*HXX.<G-C]OFOWMJW^M65B5)O:*2?=EG6ZT.$@HM,%H;'.?C@F
M0*<HKN[OGO$1HE_IG.7(?LTG&^:I0]<[Z5Q;U0.OO"MUUK4]QY@%O,"ZI':3
M<&^Z7J^BZI:C>E #X'??/+T\54_ #EW?L *1+>8.WDW;Q/(<YRTZ).T[=-CV
M!'8O:WY%O)2)=N>G9Q]#/VN!QL&?M< SSEC^6V7Y$^9ZB4.4[O>:7]DX^LI+
M)5]]?P61>WM[%4KA1(/Z\K@7HM+&44-X<9+=B^M@]DG>!9'PA]]S>C5YZQ[N
M<1?7A#,>AU$<IN+-SL[^_G=<YRG]O7A"-QB&&!Y$0W$"L![+B8S>_[@":WH1
M1D/)SX?1QM&U%/?!@Q3!()-#$:0BG<I!&(S%()Y%J1PC3H7A5+7UM4"TY3AX
M#!*),<DT3H(LC".QF=U+\6H\I+<3#B^/6O%D&D3SP]>71Z\2OKA5$V&$1Z)(
M#OB)QQ!6IZ?"-)T%T4"R(M-@+,7MG&_H240\$O]JU'8/=FH[._Q_S 1![NX2
M>&,FQ30)HT$XA=3!!&)G](#QO'YG(A7[]3<'.S]!-U$8)_#I#*H;SB2"=_?M
MX@;X&@^I[@&":"'^D"!O?SY8*<C>SK(@N/9G"7)0W]U9K9&]@Q6"'"P+PD;[
MU\^E;=;78.:72/+F"4D.5DARL"P)"5*#N]Y)#$[8N];7Z+G2DC6A/N<*9=GU
MI0-S2+G4TG[KHH\!ZO%'B2! \304TUE"/IQ1N" _7B+$DL<DS !CPH(J*#-D
M")YA0&%V+&^369#,1>-MC<0[J)''DS#0$9XP?9^N-N.1!<T,9C0CR<BA" )U
M 8H4)Y21R[O"=5NUXG(61&,Y%Z^"">"V%=?Y[OI:,T@&XV">BE8P#3,8AV;D
MM<[#WV?WL3G?9<]2<R)'T'Y&L \DG" [/&@=(F\D<IK(%+M$.J#+VLRI!/!C
M_D(C,DE%%$PD*SZ1Y+8+UEVMO*=L0'D(2K]5:033SNAQ3!YDJ*"2+( W.ISQ
M9HFL"66 @.7SX@<YN<5@MD)C%WJYE=FCE-&2!2[K=&H?1)]$/YFE67ZO)CS.
M?MB@E:8Q$B=]JG$>G0T&$M<2Y%O\@WU+/%?.\^2#&2T@Y9):^NIZ-0GP0M,I
M(P]MC!.GL?-><9-MK-6 G==%HU'51N&4NV\*IU3:4&%DJH,^:WG$)KWY22G]
M08[GB^%3+%DQ7XYH+WU/=V-E#X5:$Q_@N+_-), $^*;Z%,S7ECLJW )I[!*U
M7'CO]HW1*,FO+1^Q+$MEDKP+W4!97OXVD<&G[5N)*(*,4Y;9%.G-"HE(S">7
M7%K,[-FL;M<\4]<O>@GY.8N]F"#].71W*1*^X]QLD-U5 ? =2=U_D#?*S\$D
MC"B)("TD<ASB3W"[&!5=B.R&S)* \TV!(^MKE)3"$8](1$SI_S%,D;=I6G4=
MB3R>)>" 69B. D43D9J02^_%,![,*)%!R)QW2JR(OX=T2<T]"+(2>\R,-9W=
MCL,![F ,Z"VDH:LL!*A3BJ3+<U,N?-1;&Q+P# 7H*O(XN0.D#J;3) :EH;4U
M#A+V3^,T7Q9URUAF2/=$=P?C&56R8C/8XJ'@1"'64HPY!51R:EY?PZ?C.)F(
MWO:>U?/%YG$X5DEZ;V]O>_?M_KNW.TCV(UP=EK39@&C:B_UY<!]$=[SM";!P
M-2G7=RH,CE;7+K^^UMA7/K_XK&^*WLM%KZ+1[2R#0^2;IN<+HY$R<JL5T/_J
M?]^^V_\@-F^5=FZ#E/AB3"5(-DM7T*7]')F4:G$O5%B]6KJ72S10$DW)H^'?
MK)E2,@-S<PQ=0>G@2@L6,RQC$D9JK(O]W7WH8?-@JR P%0M; V;.C7=[>U2#
MP>18G12P8":,>Z%-0!T2.8(6J!);4,=0J6-$(8UD $]-[Z7,OL!GG[GYO3UC
MV]A#OK#,[? -JH?O?D?=0X@7*H_I$FD/\H]0'U'^F^<YR=)FHXCU):> H6B5
MR8O&.9%96*](9M4I^_=A,EPY,7C^'*7Z8D*L"1D@H1)WE!FE,:A(Q]&@*HEV
MPD1FG/\69AGFD<-_"=IT/,HM=Z<L5Q! =1VL]GY1)2?C^!9NI>@\)566+@40
ME:E<UV9\YXND-5\^I,(4MD,$T6AS/;.^6%\K"HS\R5^W8$JPO!EIOQ"@&0=0
M,CZT0V!.%B=+*(-4$7#) J^J=#7,+>A%R$B;G[84L#$( 1V_ FHE7I4^R T3
MFF,29%Q982T8G#LMK*L!4FKM&:!67U]S(C6E0G9=E^2/!]@4/4_ZI4T%,_P;
MZ#T(,]9OCOL+,M+0.QG-P!0BK$LC@_%8I.$=%H!SI(79U+RDC0BN,*%IM3X-
M2J&>+I=(9[<8F2D",6,05YRCG%;+"YS/[JF216(-!BJ:!C @(+N0C(W'JZO-
MKZ^9M2WY!#WU&"0)<@CY*&2E8JM$HR#W*=BP,*;!7RJ$@R0P[9RK.I$/H7R4
MPV(/#UM(_.,\4!Y#_%E6O>P)U(G@'ALV%++O<?J#?<%]@EMDNI$<<CG.PRE'
M(,X*C.%407?T-L +([B;3E(KD'9]K8#:PLP79:HNBT_3[1^VEJ*PK/*Q]12[
M0@4^G(WG[%ZP^^]Z@P\!:B]<+L*:+@X!T0](/<AVNFUH]AKJXGK!=;D^9E\
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MS2 YY6L]]?S==2<2=^&#JOO"M#B0 J;0*R?J[%&K,Q@J;%9',-2U)IOE[V]
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M4$L! A0#%     @ DHA:6LR<U)?C P  N!$  !$              ( !
M &%B8G8M,C R-3 R,C8N>'-D4$L! A0#%     @ DHA:6H_.&C? "0  VW8
M !4              ( !$@0  &%B8G8M,C R-3 R,C9?9&5F+GAM;%!+ 0(4
M Q0    ( )*(6EHNGTGF]0P  "^?   5              "  04.  !A8F)V
M+3(P,C4P,C(V7VQA8BYX;6Q02P$"% ,4    " "2B%I:*H#E4?8(  #/;P
M%0              @ $M&P  86)B=BTR,#(U,#(R-E]P<F4N>&UL4$L! A0#
M%     @ DHA:6JZK&-/&'   F,@  !$              ( !5B0  '1M,C4U
M-S(S9#=?.&LN:'1M4$L! A0#%     @ DHA:6L[>VGY#H0  )UD$ !0
M         ( !2T$  '1M,C4U-S(S9#=?97@T+3(N:'1M4$L! A0#%     @
MDHA:6H^,8UW&&   [EP  !0              ( !P.(  '1M,C4U-S(S9#=?
?97@U+3$N:'1M4$L%!@     '  < RP$  +C[      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>tm255723d7_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:abbv="http://abbvie.com/20250226"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:exch="http://xbrl.sec.gov/exch/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="abbv-20250226.xsd" xlink:type="simple"/>
    <context id="AsOf2025-02-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="From2025-02-262025-02-26_us-gaap_CommonStockMember_exch_XNYS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="From2025-02-262025-02-26_exch_XCHI_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XCHI</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="From2025-02-262025-02-26_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes0.750Percentdue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="From2025-02-262025-02-26_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes2.125Percentdue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="From2025-02-262025-02-26_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes2.625Percentdue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="From2025-02-262025-02-26_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes2.125Percentdue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="From2025-02-262025-02-26_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes1.250Percentdue2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-02-26" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-02-26" id="Fact000004">0001551152</dei:EntityCentralIndexKey>
    <dei:Security12bTitle
      contextRef="From2025-02-262025-02-26_exch_XCHI_us-gaap_CommonStockMember"
      id="xdx2ixbrl0046">Common Stock, $0.01 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-02-262025-02-26_exch_XCHI_us-gaap_CommonStockMember"
      id="xdx2ixbrl0047">ABBV</dei:TradingSymbol>
    <dei:DocumentType contextRef="AsOf2025-02-26" id="Fact000010">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-02-26" id="Fact000011">2025-02-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-02-26" id="Fact000012">ABBVIE INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-02-26" id="Fact000013">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-02-26" id="Fact000014">001-35565</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-02-26" id="Fact000015">32-0375147</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-02-26" id="Fact000016">1 North Waukegan Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-02-26" id="Fact000017">North Chicago</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-02-26" id="Fact000018">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-02-26" id="Fact000019">60064-6400</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-02-26" id="Fact000020">847</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-02-26" id="Fact000021">932-7900</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-02-26" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-02-26" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-02-26" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-02-26" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-02-26" id="Fact000026">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle
      contextRef="From2025-02-262025-02-26_us-gaap_CommonStockMember_exch_XNYS"
      id="Fact000027">Common     Stock, $0.01 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-02-262025-02-26_us-gaap_CommonStockMember_exch_XNYS"
      id="Fact000028">ABBV</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-02-262025-02-26_us-gaap_CommonStockMember_exch_XNYS"
      id="Fact000029">NYSE</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="From2025-02-262025-02-26_exch_XCHI_us-gaap_CommonStockMember"
      id="Fact000030">CHX</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-02-262025-02-26_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS"
      id="Fact000031">0.750%     Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-02-262025-02-26_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS"
      id="Fact000032">ABBV27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-02-262025-02-26_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS"
      id="Fact000033">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-02-262025-02-26_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS"
      id="Fact000034">2.125%     Senior Notes Due 2028</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-02-262025-02-26_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS"
      id="Fact000035">ABBV28</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-02-262025-02-26_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS"
      id="Fact000036">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-02-262025-02-26_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS"
      id="Fact000037">2.625%     Senior Notes Due 2028</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-02-262025-02-26_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS"
      id="Fact000038">ABBV28B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-02-262025-02-26_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS"
      id="Fact000039">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-02-262025-02-26_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS"
      id="Fact000040">2.125%     Senior Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-02-262025-02-26_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS"
      id="Fact000041">ABBV29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-02-262025-02-26_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS"
      id="Fact000042">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-02-262025-02-26_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS"
      id="Fact000043">1.250%     Senior Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-02-262025-02-26_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS"
      id="Fact000044">ABBV31</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-02-262025-02-26_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS"
      id="Fact000045">NYSE</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
